JP2011518876A - Homeopathic formulation - Google Patents

Abstract

  The present invention relates to homeopathic preparations for the treatment of neurological diseases.

Description

  The present invention relates to homeopathic formulations, in particular to homeopathic formulations for the treatment of neurological disorders.

  People affected by neurological disorders, including intellectual disability, account for 1 to 3% of the global population, according to the World Health Organization (WHO) estimate. The rehabilitation of patients suffering from the disease mainly relies on assistive engineering, speech therapy, behavioral therapy, occupational therapy, counseling, and treatment / treatment methods such as seizure, involuntary movement, symptomatic drug therapy for spasm, and corrective surgery. There is. At present, there are only a limited number of treatments for the disease and it is generally considered incurable. Therefore, effective medical drug treatment of the disease can be said to be a difficult task in the medical field.

  The history of homeopathy dates back to the 18th century, beginning with the study of German doctor Samuel Hahnemann who hypothesized the law that "like treats similar". In the 19th century, Dr. Fugo Paul Friedrich Schulz suggested that small doses may have an adverse effect, as compared to high doses of toxin. In 1888, Dr. Schulz proved that the extremely diluted yeast toxin enhanced the growth of yeast by a factor of 100. Also, Rudolf Arntz, a psychiatrist, encourages all reactions to the body if it is a weak one, and moderate ones to a greater degree and strong ones to a greater degree. We have created the "Basic Law of Biology," which means that even stronger stimuli can be stopped. In 1888, Dr. Ernst summarized these insights into the law of the homeopathic effect of Ernz Schulz, and established one of the oldest pharmacology. According to this law, any stimulation of living cells promotes a reaction that is inversely proportional to the strength of the stimulation (Martius F., 1923, Das Arndt-Schultz Grundgesetz, Muench Med. Wschr., 70 (31): 1005- 1006). This law was later recapitulated by Dr. Ferdinand Hüppe that, for any substance, small doses are irritating, medium doses are restraining, and large doses are extinguished.

  An allopathic therapy with emphasis on moderate drug administration is effective in suppressing unwanted physical symptoms and in killing harmful pathogens. Conversely, homeopathic therapy starts with small doses and gradually increases dilution to stimulate the body's natural electromagnetic force. One of the basic principles of homeopathic remedies is that it is similar to the etiology and yet it is possible to treat the disease by using high dilutions of different drugs.

  In over 100 homeopathic comparative trials or clinical trials, patients were able to obtain more than a placebo effect from homeopathy (Jonas et al, 2003, Ann. Intern. Med. 138: 393-399; Linde et al, 1997, Lancet. 350 (9081): 834-843; Reilly et al, 1994, Lancet. 344: 1601-1606); Kleijnen et al, 1991, Bmj. 910418 302 (6772): 316-323). Homeopathy is widely accepted in Europe, North America, Commonwealth countries, and India as an effective treatment.

  Ayurveda mentions the effects of small doses in disease treatment. Ayurveda (Ayurveda) is a word that combines two words: AYU, which means life, and VEDA, which means science and knowledge, to mean "life science".

  Ayurveda complains that ineffective substances do not exist in this world. VAIDYA (Ayurvedic Doctor) has a duty to utilize its intelligence and keep thinking about new combinations of treatment, ie KALPA, in order to bring the patient to a healthy state. Ayurveda states that the substance is effective in the body with its characteristic GUNA. The medical properties of the substance can be further enhanced by being used in various treatments SANSKAR. With SANSKAR, the medical characteristics GUNA rise and fall, sometimes SANSKAR can convert the point of action of a substance into the body. The so-called SANSKARS, which incorporates drugs into different treatments, enables the administration of a small amount of the drug SOOKSHMA, resulting in higher efficacy and lower side effects. The drug penetrates deep inside the body called SOOKSHMA, and from its tiny size, it enters the smallest part of the body's circulatory pathways called SROTA SAS. SOOKSHMA means a trace amount or a minuteness, and its property enables quick absorption inside SROTASAS. SROTASAS was named for the tendency of secretions to drip or exude through the part (SRU means flow) (the secretions may also be correlated with neurotransmitters). SROTASAS is a nutrient, waste product, DOSHAS (DOSHAS is described in Ayurveda as being healthy when the body is in equilibrium, and is said to cause a lesion in the body when the equilibrium is disturbed) when metabolism is performed. It is a route. When the basal site of SROTASAS with various functions is in the normal state, its openings are innumerable (openings are comparable to synaptic neuronal connections). The drug before it is absorbed in the digestive tract circulates throughout the body, and what is later digested is called VYAVAYI. Because of the properties of VYAVAYI, the drug is absorbed instantly and immediately acts on the details of SROTA SAS. A drug that spreads quickly throughout the body and acts quickly after administration is called AASHUKARI.

According to the basic principle of Ayurvedic pharmacology, two drugs with similar characteristics GUNAS are said to enhance their potential (synergistic effect). The drug is given to the mind in a pleasant way. The drug is preferably given in a variety of ways and properties, GUNAS. An ideal drug has the following characteristics:
Effective at low doses Can act on various pathologies (DOSHAS) with immediate action
Easy to be absorbed Good taste
Allows you to treat pleasant illness or improve symptoms

  According to Ayurveda, it is desirable for the treatment of neurological disorders to include a component that provides a mild suppression of neurological symptoms. It is the so-called SHAMANA CHIKITSA. For this purpose, minerals of plants and bodies that act on neurological symptoms and diseases are used.

  Many homeopathic formulations are developed in the prior art, such as US Pat. No. 7,229,648, which discloses homeopathic formulations for the treatment of pain and inflammation. U.S. Pat. No. 7,037,532 discloses a soothing alleviation composition containing an aqueous ethanol tincture mixture containing six to seven homeopathic ingredients. However, these preparations are not intended for the treatment of neurological disorders.

  US Patent Publication 2006/0088575 discloses purified growth factors including nerve growth factor (NGF), and purified growth hormone, a homeopathic formulation of an accompanying carrier. Although the preparation is suitable for treatment of mature spinal cord, chronic damage to sensory afferent nerve, olfactory disorder, sensory regression, microglia inactivation, etc., cerebral palsy, intellectual disorder, autism, down syndrome, general development It is not intended to treat neurological disorders such as retardation, developmental disorders, neurological disorders, brain damage, various neurological syndromes, neurometabolic disorders, or stroke.

  Thus, there is a need for inexpensive homeopathic formulations that are effective for the treatment of neurological disorders, including those described above.

  The object of the present invention is to provide homeopathic preparations for treating neurological diseases.

  Another object of the present invention is spastic cerebral palsy (spastic, hyptonic, athetoid), ataxia-type cerebral palsy, intellectual disability, depression due to neurological disease, autism, down syndrome, overall developmental delay, developmental disorder, nerve Disorders, brain damage, neurometabolic disorders, stroke, attention deficit disorder, attention deficit hyperactivity disorder, apela syndrome, cleft encephalopathy, congenital brain deformities such as spinach hypertrophy, poroencephalopathy, dystonia, familial mental retardation, Infantile hemiplegia, jaundice, learning disorder, multiple cerebral infarction dementia, microcephaly, metabolic disorder with neurological complication, postmeningoencephalitis brain injury, Rubinstein-Taibi syndrome, Rett syndrome, postoperative neuropathy , Multiple sclerosis, subacute sclerosing encephalitis, and Lee's encephalopathy, Cornelia de Lange's syndrome, Japanese encephalitis, tuberous sclerosis, cerebral white matter atrophy, chromosomal abnormalities, callosal defect, spinal cerebellar syndrome etc. Various syndromes, Disorders, also including such neurological disorders, and to provide an effective homeopathic preparations to some non-limiting neurologic abnormalities thereto.

  Another object of the present invention is to provide a stable homeopathic formulation.

  Yet another object of the present invention is to provide a non-toxic homeopathic formulation.

  Yet another object of the present invention is to provide homeopathic formulations without any side effects.

  Yet another object of the present invention is to provide a simple homeopathic formulation of the preparation.

  Yet another object of the present invention is to provide homeopathic formulations which can be combined with other homeopathic formulations to obtain the desired effect.

  Yet another object of the invention is to provide homeopathic formulations that are compatible with conventional and other therapies.

  Yet another object of the present invention is to provide a cost effective homeopathic formulation.

According to the present invention, there is provided a preparation for treating neurological diseases comprising a tincture consisting of the following, or a homeopathic preparation, together with a physiologically acceptable carrier.

At least one selected from the first group containing onion (Allium cepa), Arnica montana (Arnica montana), daisies (Bellis perennis), calendula (Calendula officinalis), Sturgeon (Hypericum perforatum), and phosphoric acid (Phosphoricum acidum) component

Aconit (Aconitum napellus), alumina (Alumina), peyote cactus (Anhalonium lewini), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), arsenic trioxide (Arsenicum album), Belladonna (Belladonna), blue khosh ( Cauphyllum thalictroides), Causticum, Causticum, Cocculus indicus, Venom Ginseng (Conium maculatum), Copper (Cuprum metallicum), Curare, Curuka, Dulcamara, Red Ant (Formica rufa), Carolina Jasmine Gelsemium sempervirens), Hypericum perforatum, potassium iodide (Kalium iodatum), potassium tartaricum (Kalium tartaricum), American rhubarb (Kalmia latifolia), Bushmaster (Lachesis mutus), Glass bean (Lathyrus sativus), hasselti), manganese Tate (Manganum aceticum), mercuric chloride (Mercurius corrosivus), matin (Nux vomica), oxalic acid (Oxalicum acidum), white phosphorus (Phosphorus), carabalu bean (Physostigma venenosum), picric acid (Picricum acidum), plumbiacetate At least one selected from the second group containing (Plumbum aceticum), poison (Rhus toxicodendron), ergot (Secale cornutum), strykininpurum (Strychninum purum), thallium (Thaelium metallicum), and thoroidinum (Thyroidinum) component

Silver nitrate (Argentum nitricum), atropine (Atropinum), aurum metallicum (Aurum metallicum), barium carbonate (Baryta carbonica), Belladonna (Belladonna), oyster shell nacre (Calcarea carbonica), potassium hydroxide (Causticum), Greater selandin (Chelidonium majus), rattlefish snake (Crotalus horridus), yellow jasmine (Gelsemium sempervirens), blue sweet pea (Lathyrus sativus), lycopodium clavatum, martin (Nux vomica), oxalic acid (Oxalicumum) Containing (Phosphorus), Calabar (Physostigma venenosum), Lead (Plumbum metallicum), Crystal (Slicea terra), Strychninum purum, Sulfur (Sulphur), Tarantula (Tarentula hispanica), and Thuja occidentalis At least one component selected from three groups

From the fourth group that contains barium carbonate (Baryta carbonica), oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), potassium hydroxide (Causticum), sodium chloride (Natrium muriaticum), and crystal (Silicea terra) Selected at least one ingredient

Mugwort (Absinthium), aconit (Aconitum napellus), dog parsley (Aethusa cynapium), Amaranth (Agnus castus), aluminum (Alumina), ambragricia (Ambra grisea), marking nut (Anacardium orientale), aurora cactus (Anhalonium) lewinii), silver nitrate (Argentum nitricum), arnica montana (Arnica montana), gold (Aurum metallicum), neem (Azadirachta indica), barium carbonate (Baryta carbonica), marigold (Calendula officinalis), pearl layer of oyster shell ( Calcarea carbonica, calcium phosphate (Calcarea phosphorica), camphora officinalis (Camphora officinalis), Indian cannabis (Cannabis indica), plant charcoal (Carbo vegitabilis), Tussock ginseng (Cocculus indicus), poisonous ginseng (Conium maculatum), glycerin (Glycerinum) ), Ifthyol (Ichthyolum), potassium bromide (Kalium Bromatum), potassium carbonate (Kalium carbonicum), potassium phosphate (Kalium phosphoricum), dog's milk (Lac caninu), bushmaster (Lachesis mutus), lecithin (Lecithinum), hinocangula (Lycopodium clavatum), gonorrhea Medorrhinum), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), sodium carbonate (Natrium carbonicum), sodium chloride (Natrium muriaticum), nitric acid (Nitricum acidum), nutmeg (Nux moschata), matin (Nux vomica), ole Under = 夾 桃 (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), lead (Plumicum metallicum), rhodedendron (Rhododendron chrysanthum) Poison ivy and poison oak (Rhus toxicodendron), selenium (Selenium metallicum), Europe Squid squid (Sepia officinalis), crystal (Silicea terra), sulfur (Sulphur), rigid lower exudate (Syphilinum) of patients with syphilis, tellurium (Tellurium metallicum), thyroidinum (Thyroidinum), zinc (Zincum metallicum), zincic acid (Zincum) phosphoricum, at least one component selected from the fifth group containing zinc picrate (Zincum picricum)

Ohio Horse Chestnut (Aesculus glabra), Agaricus muscarius (Agaricus muscarius), Marking Nut (Anacardium orientale), Ubatama Cactus (Anhalonium lewinii), Atropininum (Atropninum), Barium Carbonate (Baryta carbonica), Belladonna (Belladonna), Hellopus luciferus ), Bovista licoperdon (Bovista lycoperdon), European toad (Buforana), cannabis (Cannabis indica), hemp (Cannabis sativa), potassium hydroxide (Causticum), cereus serpentinus (Cereus serpentinus), doxcilli (Cicuta virosa) ), Copper (Cuprum metallicum), Yellow jasmine (Gelsemium sempervirens), Hyos (Hyoscyamus niger), Ignatius beans (Ignatia amara), Potassium bromide (Kalium bromatum), Potassium cyanide (Kalium cyanatum), Bushmaster (Lachesis mutus), Bacchi Arhus (Laurocerasus), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), South African pink toe (Mygale lasiodora), Indian cobra (Naja tripudians), sodium chloride (Natrium muriaticum), nutmeg (Nux moschata), oleander = Containing Peach bamboo peach (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), white phosphorus (Phosphorus), chrysanthemum (Stramonium), sulphonalum (Sulfonalum), black-and-white sorrel (Thuja occidentalis), and the European goldfish (Vipera berus) At least one component selected from six groups

Dog parsley (Aethusa cynapium), Sambusia nirvana (Ailanthus glandulosa), alfalfa (Alfalfa), marking nut (Anacardium orientale), Ubata cactus (Anhalonium lewinii), silver nitrate (Argentum nitricum), oat (Avena sativa), Wild indigo , Oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), coca (Coca-Erythroxylon coca), clover (Cocculus indicus), copper (Cuprum metallicum), yellow jasmine (Gelsemium sempervirens), potassium bromide (Kalium) Bromatum), potassium phosphate (Kalium phosphoricum), lecithin (Lecithinum), sodium chloride (Natrium muriaticum), matin (Nux vomica), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), (Silicea terra), strychnine neric acid (Stychninum phosphori (cum), zinc (Zincum metallicum), zinc acid (Zincum phosphoricum), zinc picrate (Zincum picricum) at least one component selected from the seventh group containing

Belladonna (Belladonna), Toad Toad (Buforana), Spanish moth (Cantharis vesicatoria), Copper (Cuprum metallicum), Hyos (Hyoscyamus niger), Tiger Lily (Lilium tigrinum), Ercorn (Secale cornutum), Chosen Asagao (Stramonium) At least one component selected from the eighth group containing Tarantula (Tarentula hispanica), Veratrum album, and

Horse mackerel (Aconitum napellus), Agaricus muscarius (Agaricus muscarius), Bee (Apis mellifica), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenic trioxide (Arsenicum album), atropine (Atropinum), veradonna (Atropinum) Belladonna), benzoicum acidum, oyster shell nacre (Calcarea carbonica), spanish salmon (Cantharis vesicatoria), potassium hydroxide (Causticum), dokuseri (Cicuta virosa), American ginger (Cimicifuga racemosa), Sina Maritina (Cina maritima), Poisonous Ginseng (Conium maculatum), Woody Nightshade (Dulcamara), Toxa (Equisetum hyemale), Eryngium aquaticum (Eryngium aquaticum), Bone Set (Eupatorium perfoliatum), Joe Pi Suites (Eupatorium purpureum) ), Iron (Ferrum metallicum), iron phosphate (Ferrum) phosphoricum, yellow jasmine (Gelsemium sempervirens), hydrangea (Hydrangea arborescens), hyos (Hyoscyamus niger), potassium bromide (Kalium bromatum), potassium nitrate (Kalium nitricum), potassium phosphate (Kalium phosphorousum), cleosome (Kreosotum) ), Liana vulgaris, lupulus humulus, lycopodium clavatum, magnesium phosphate (Magnasia phosphorica), gonorrhea (Medorrhinum), matin (Nux vomica), poppy (Opium-Papaver omnium) Petroleum (Petroleum), Phosphoric acid (Phosphoricum acidum), Calaba bean (Physostigma venenosum), Horseradish (Plantago major), Horsetail (Pulsatilla pratensis), Rhushi (Rhus aromatica), Poison Ivy and Poisoned Oak (Rhus nicotinose) Sabal serrulata), Sanuki in Ottawa Cretaceous water (Sanicula aqua), Santonin (Santoninum), Ercorn (Secale cornutum), Senega (Senega), Eurasian Squid (Sepia officinalis), Crystal (Silica terra), Ginseng (Stramonium), Sulfur (Sulphur), Tv oil (Terebinthiniae oleum), Thyroidinum, Thuja occidentalis, Triticum repens-Agropyrum repens, Tuberculinum bovinum Kent, Uranium nitrate (Uranium niutilus) And at least one component selected from the ninth group containing zinc (Zincum metallicum)

  In general, the preparation is effective for treating neurological diseases in humans and may also be effective for treating neurological diseases in animals.

  Usually, this ingredient is a tincture.

  It is preferable that each component is fortified.

  The ingredients are usually aqueous extracts.

  It is desirable that the component is an ethanol solution.

  In general, the ingredients are effective from tincture to all X, C, LM (dilution ratio 1: 50,000) or more, and preferably about 30 C to 1 M.

  Usually, the efficacy is either X efficacy or C efficacy.

  Generally, the physiologically acceptable carrier is selected from the group consisting of whey, sucrose, calcium carbonate, microcrystalline cellulose, carbon, carnauba wax, croscarmellose sodium, stearic acid, magnesium stearate, silicon dioxide, ethanol Be done.

  Usually, the dose of each component of the group has a width of about 1: 1 to 1:10 relative to the dose of the other groups.

  In general, the preparation is in a form selected from the group consisting of tablets, capsules, powders, globules, lozenges, pills, pellets, solutions, syrups, elixirs, suspensions, emulsions.

According to a preferred embodiment of the present invention, there is provided a preparation for treating a neurological disease comprising the following ingredients together with a physiologically acceptable carrier.
i) Arnica montana
ii) Hypericum perforatum
iii) Causticum
iv) Hyos (Hyoscyamus niger)
v) Zinc acid (Zincum phosphoricum)
vi) Sodium chloride (Natrium muriaticum)
vii) Calcium phosphate (Calcarea phosphorica)
viii) potassium phosphate (Kalium phosphoricum) and
ix) Iron phosphate (Ferrum phosphoricum)

  According to another preferred embodiment of the present invention, daisies (Bellis perennis) with efficacy of as much as 30 C to 1 M, calcareous nacre (Calcarea carbonica), alfalfa with a physiologically acceptable carrier Provided is a preparation comprising (Alfalfa), oat (Avena sativa), zinc (Zincum metallicum), Sturgeon (Stramonium), Causticum (Causticum), sodium chloride (Natrium muriaticum), potassium phosphate (Kalium phosphoricum).

According to yet another aspect of the present invention, there is provided a method of formulating neurological disease treatment, comprising the following procedure.
i) Selection at least one component from the first group above at least one component from the second group above at least one component from the third group above at least one component from the fourth group above at least one component from the fifth group above At least one component from the sixth group At least one component from the above seventh group At least one component from the above eighth group At least one component from the above ninth group

ii) making a mixture containing the selected components in a ratio of about 1: 1 to 1:10 with respect to the other group

iii) Dilute the mixture with a liquid carrier selected from water or ethanol to obtain a potent mixture between tincture and LM potency, possibly in the range of 30 C to 1 M

iv) Immerse the carrier globule in the dilution mixture to obtain the formulation

  According to yet another aspect of the present invention, a homeopathic formulation is obtained wherein each component is uniquely enhanced and then a predetermined level of fortifying solution is mixed to allow later immersion in the carrier globule.

  Alternatively, formulations of each component can be obtained from goods and added to the carrier globule.

  Usually, the carrier globule is sucrose globule or lactose globule.

In yet another aspect of the invention, a method for treating neurological disorders in a subject, administering a dose of the formulation comprising an extract from: The above described approaches are presented.

At least one selected from the first group containing onion (Allium cepa), Arnica montana (Arnica montana), daisies (Bellis perennis), calendula (Calendula officinalis), Sturgeon (Hypericum perforatum), and phosphoric acid (Phosphoricum acidum) component

Aconitum (Aconitum napellus), Alumina (Alumina), Peyote Cactus (Anahalonium lewini), Silver Nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenide trioxide (Arsenicum album), Belladonna (Belladonna), Blue Khosh (Caulophyllum thalictroides), Causticum, Causticum, Cocculus indicus, Poisonous Ginseng (Conium maculatum), Copper (Cuprum metallicum), Curare, Curuka, Dulcamara, Red Ant (Formica rufa), Carolina Jasmin (Gelsemium sempervirens), Hypericum perforatum, potassium iodide (Kalium iodatum), potassium tartaricum (Kalium tartaricum), American rhubarb (Kalmia latifolia), bushmaster (Lachesis mutus), glass bean (Lathyrus sativus) Latrodectus hasselti), manganese acetate Tate (Manganum aceticum), mercuric chloride (Mercurius corrosivus), matin (Nux vomica), oxalic acid (Oxalicum acidum), white phosphorus (Phosphorus), carabalu bean (Physostigma venenosum), picric acid (Picricum acidum), plumbiacetate At least one selected from the second group containing (Plumbum aceticum), poison (Rhus toxicodendron), ergot (Secale cornutum), strykininpurum (Strychninum purum), thallium (Thaelium metallicum), and thoroidinum (Thyroidinum) component

Silver nitrate (Argentum nitricum), atropine (Atropinum), aurum metallicum (Aurum metallicum), barium carbonate (Baryta carbonica), Belladonna (Belladonna), oyster shell nacre (Calcarea carbonica), potassium hydroxide (Causticum), Greater selandin (Chelidonium majus), rattlefish snake (Crotalus horridus), yellow jasmine (Gelsemium sempervirens), blue sweet pea (Lathyrus sativus), lycopodium clavatum, martin (Nux vomica), oxalic acid (Oxalicumum) Containing (Phosphorus), Calabar (Physostigma venenosum), Lead (Plumbum metallicum), Crystal (Slicea terra), Strychninum purum, Sulfur (Sulphur), Tarantula (Tarentula hispanica), and Thuja occidentalis At least one component selected from three groups

From the fourth group that contains barium carbonate (Baryta carbonica), oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), potassium hydroxide (Causticum), sodium chloride (Natrium muriaticum), and crystal (Silicea terra) Selected at least one ingredient

Mugwort (Absinthium), aconit (Aconitum napellus), dog parsley (Aethusa cynapium), Amaranth (Agnus castus), aluminum (Alumina), ambragricia (Ambra grisea), marking nut (Anacardium orientale), aurora cactus (Anhalonium) lewinii), silver nitrate (Argentum nitricum), arnica montana (Arnica montana), gold (Aurum metallicum), neem (Azadirachta indica), barium carbonate (Baryta carbonica), marigold (Calendula officinalis), pearl layer of oyster shell ( Calcarea carbonica, calcium phosphate (Calcarea phosphorica), camphora officinalis (Camphora officinalis), Indian cannabis (Cannabis indica), plant charcoal (Carbo vegitabilis), Tussock ginseng (Cocculus indicus), poisonous ginseng (Conium maculatum), glycerin (Glycerinum) ), Ifthyol (Ichthyolum), potassium bromide (Kalium Bromatum), potassium carbonate (Kalium carbonicum), potassium phosphate (Kalium phosphoricum), dog's milk (Lac caninu), bushmaster (Lachesis mutus), lecithin (Lecithinum), hinocangula (Lycopodium clavatum), gonorrhea Medorrhinum), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), sodium carbonate (Natrium carbonicum), sodium chloride (Natrium muriaticum), nitric acid (Nitricum acidum), nutmeg (Nux moschata), matin (Nux vomica), ole Under = 夾 桃 (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), lead (Plumicum metallicum), rhodedendron (Rhododendron chrysanthum) Poison ivy and poison oak (Rhus toxicodendron), selenium (Selenium metallicum), Europe Squid squid (Sepia officinalis), crystal (Silicea terra), sulfur (Sulphur), rigid lower exudate (Syphilinum) of patients with syphilis, tellurium (Tellurium metallicum), thyroidinum (Thyroidinum), zinc (Zincum metallicum), zincic acid (Zincum) phosphoricum, at least one component selected from the fifth group containing zinc picrate (Zincum picricum)

Ohio Horse Chestnut (Aesculus glabra), Agaricus muscarius (Agaricus muscarius), Marking Nut (Anacardium orientale), Ubatama Cactus (Anhalonium lewinii), Atropininum, Barium Carbonate (Baryta carbonica), Belladonna (Belladonna), Bacillus Chirocerus ), Bovista licoperdon (Bovista lycoperdon), European toad (Buforana), cannabis (Cannabis indica), hemp (Cannabis sativa), potassium hydroxide (Causticum), cereus serpentinus (Cereus serpentinus), doxcilli (Cicuta virosa) ), Copper (Cuprum metallicum), Yellow jasmine (Gelsemium sempervirens), Hyos (Hyoscyamus niger), Ignatius beans (Ignatia amara), Potassium bromide (Kalium bromatum), Potassium cyanide (Kalium cyanatum), Bushmaster (Lachesis mutus), Bacchi Ki (Laurocerasus), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), South African pink toe (Mygale lasiodora), Indian cobra (Naja tripudians), sodium chloride (Natrium muriaticum), nutmeg (Nux moschata), oleander = Containing No. bamboo peach (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), white phosphorus (Phosphorus), chrysanthemum (Stramonium), Sulfonalum (Sulfonalum), European sturgeon (Thuja occidentalis), and the European snapper (Vipera berus) At least one component selected from six groups

Dog parsley (Aethusa cynapium), Sambusia nirvana (Ailanthus glandulosa), alfalfa (Alfalfa), marking nut (Anacardium orientale), Ubata cactus (Anhalonium lewinii), silver nitrate (Argentum nitricum), oat (Avena sativa), Wild indigo , Oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), coca (Coca-Erythroxylon coca), clover (Cocculus indicus), copper (Cuprum metallicum), yellow jasmine (Gelsemium sempervirens), potassium bromide (Kalium) Bromatum), potassium phosphate (Kalium phosphoricum), lecithin (Lecithinum), sodium chloride (Natrium muriaticum), matin (Nux vomica), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), (Silicea terra), strychnine neric acid (Stychninum phosphori (cum), zinc (Zincum metallicum), zinc acid (Zincum phosphoricum), zinc picrate (Zincum picricum) at least one component selected from the seventh group containing

Belladonna (Belladonna), Toad Toad (Buforana), Spanish moth (Cantharis vesicatoria), Copper (Cuprum metallicum), Hyos (Hyoscyamus niger), Tiger Lily (Lilium tigrinum), Ercorn (Secale cornutum), Chosen Asagao (Stramonium) At least one component selected from the eighth group containing Tarantula (Tarentula hispanica), Veratrum album, and

Horse mackerel (Aconitum napellus), Agaricus muscarius (Agaricus muscarius), Bee (Apis mellifica), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenic trioxide (Arsenicum album), atropine (Atropinum), veradonna (Atropinum) Belladonna), benzoicum acidum, oyster shell nacre (Calcarea carbonica), spanish salmon (Cantharis vesicatoria), potassium hydroxide (Causticum), dokuseri (Cicuta virosa), American ginger (Cimicifuga racemosa), Sina Maritina (Cina maritima), Poisonous Ginseng (Conium maculatum), Woody Nightshade (Dulcamara), Toxa (Equisetum hyemale), Eryngium aquaticum (Eryngium aquaticum), Bone Set (Eupatorium perfoliatum), Joe Pi Suites (Eupatorium purpureum) ), Iron (Ferrum metallicum), iron phosphate (Ferrum) phosphoricum, yellow jasmine (Gelsemium sempervirens), hydrangea (Hydrangea arborescens), hyos (Hyoscyamus niger), potassium bromide (Kalium bromatum), potassium nitrate (Kalium nitricum), potassium phosphate (Kalium phosphorousum), cleosome (Kreosotum) ), Liana vulgaris, lupulus humulus, lycopodium clavatum, magnesium phosphate (Magnasia phosphorica), gonorrhea (Medorrhinum), matin (Nux vomica), poppy (Opium-Papaver omnium) Petroleum (Petroleum), Phosphoric acid (Phosphoricum acidum), Calaba bean (Physostigma venenosum), Horseradish (Plantago major), Horsetail (Pulsatilla pratensis), Rhushi (Rhus aromatica), Poison Ivy and Poisoned Oak (Rhus nicotinose) Sabal serrulata), Sanuki in Ottawa Cretaceous water (Sanicula aqua), Santonin (Santoninum), Ercorn (Secale cornutum), Senega (Senega), Eurasian Squid (Sepia officinalis), Crystal (Silica terra), Ginseng (Stramonium), Sulfur (Sulphur), Tv oil (Terebinthiniae oleum), Thyroidinum, Thuja occidentalis, Scutellariae Triticum repens-Agropyrum repens, Tuberculinum bovinum Kent, Uranium nitrate And at least one component selected from the ninth group containing zinc (Zincum metallicum)

  Usually, homeopathic preparations are spastic cerebral palsy (spastic, hyptonic, athetoid), ataxia cerebral palsy, intellectual disability, depression due to neurological disease, autism, down syndrome, overall developmental delay, developmental disorder, neuropathy, Brain damage, neurometabolic disorder, stroke, attention deficit disorder, attention deficit hyperactivity disorder, apela syndrome, cleft encephalopathy, congenital brain malformation such as spinach hypertrophy, porencephalythm, dystonia, familial mental retardation, infantile piece Paralysis, jaundice, learning disorder, multiple cerebral infarction dementia, microcephaly, metabolic disorder with neurological complications, postmeningoencephalitis brain injury, Rubinstein-Taibi syndrome, Rett syndrome, postoperative neuropathy, multiple Sclerosis, subacute sclerosing encephalitis, and Lee's encephalopathy, Cornelia de Lange's syndrome, Japanese encephalitis, nodular sclerosis, cerebral white matter atrophy, chromosomal abnormalities, corpus callosum defect, spinal cerebellar syndrome, etc. Symptoms , Developmental disorders, also including such neurological diseases, it is effective to some non-limiting neurologic abnormalities thereto.

  According to the present invention, a formulation based on the law of synergy effect of various homeopathic drugs to be complemented is provided, and combined to create a unique treatment of holistic healing and various neurological diseases.

  The development of the present invention is based on the homeopathic law. The potentiation diluent of the combination of the present invention is a small dose administration according to Ferdinand Huppe's law, "Any dose is a stimulus, a moderate dose is a suppression, a large dose is a death, regardless of the substance." Stimulate at

  The reinforcing diluents of the combinations of the present invention are catalysts that follow the law of "similar cures similar" or promote treatment. The components of the present invention such as sodium chloride (Natrium Muriaticum or sodium = Sodium), calcium phosphate (Calcerea Phosphorica or calcium = Calcium), potassium phosphate (Kalium Phosphoricum or potassium = Potassium), etc. It is hypothesized to correspond. In addition, it is also hypothesized that minerals formulated into homeopathic flow in the present invention return abnormal molecular motion to a normal state. In addition, it has been hypothesized that the minerals of the present invention reactivate chemical changes in neurotransmission while the herbal extract is a catalyst to promote improvement. Presumably, the present invention eliminates synapse level disorders or promotes myelination. The component of the present invention is considered to be able to supply more oxygen to cells in the body to improve blood iron and hemoglobin levels, and to enhance metabolism and patient immunity.

  The development of the present invention finds it by chance in the Ayurvedic law described above. For example, the combination has a synergistic effect, is made using a new combination of treatments (KALPA), is administered in small amounts (SOOKSHMA), acts immediately before being digested in the digestive tract (VYAVAYI), and the body immediately Cross over (ASHUKARI), comfortable, acting on various pathologies.

  In this respect, the present invention relates to neurological diseases such as cerebral palsy, intellectual disability, autism, Down syndrome, total developmental delay, neuropathy, brain injury, various neurological syndromes, neurometabolic disorders, stroke, etc. We disclose the efficacy of the preparation in many cases and show that it will be a breakthrough invention in the medical field.

  This description is only an illustration of the present invention and does not limit its scope.

  In this patent specification, the terms "tincture" and "homeopathic preparation" of ingredients refer to a part or combination of ingredients or an extract of the ingredient itself. “Tinky” is a solvent such as alcohol or water, and it is possible to take out and dispense a part of or a combination thereof, or the component itself. The component "tincture" is preferably a mother liquor of the component formulated according to the procedures of the Homeopathic Pharmacopoeia (HPUS). A "homeopathic preparation" can be made of a liquid and tincture dilution suitable for preparation such as water or alcohol. The "homeopathic preparation" of the components in the formulation of the invention follows the procedures of the US Homeopathic Pharmacopoeia (HPUS) that the mother liquor of the components is continuously diluted and shaken according to the finish efficacy using fortification procedures known in homeopathic technology. It is preferred that the

  Furthermore, the term "efficacy" of homeopathic therapy means how many repeated dilution and shaking procedures (referred to as intensification) have been taken, and thereby how far it has changed from its original state or material form. This procedure is performed on different criteria of 1/10, 1/100, 150,000.

  1/10 (1:10) Roman number D efficacy (D means 1/10 Decimal) or X efficacy is described. One portion of the original liquid substance is added to 9 portions of a carrier such as alcohol and shaken 10 times. The product is described as D1 or 1X. This one portion is then added to the nine portions of alcohol and shaken 10 times to become D2 (2X) and so on. The drug that has taken this procedure 30 times becomes D30 (30X).

  For non-liquid fortification, procedures are carried out with lactose as the carrier rather than alcohol, and are crushed rather than shaken. When a dilution of 1: 1,000,000 (6 × or D6) is reached, the insoluble material becomes soluble and the preparation can be carried out in liquid medium as described above.

  It is described as 1 / 100th (1: 100) C efficacy (C is Centessimal meaning 1/100). One portion of the original liquid substance is added to 99 portions of a carrier such as alcohol and shaken 10 times. The product is described as C1 or 1C. This one portion is then added to 99 of the alcohol and shaken 10 times to 2C etc. A drug that has taken this procedure 30 times becomes 30C, 200 times becomes 200C, and so on. For the purpose of simplifying the marking, use Roman numerals to reduce the numbers as they become more effective. For example, 1000 C is abbreviated as 1 M (M is Millessimal which means 1/1000, or 1000), 10,000 C = 10 M, 50,000 C = 50 M, 100,000 C = CM, 1,000,000 C = MM, etc. .

  For non-liquid fortification, procedures are carried out with lactose as the carrier rather than alcohol, and are crushed rather than shaken. Upon reaching a dilution of 1: 1,000,000 (3 C), the insoluble material becomes soluble, allowing the preparation to be carried out in a liquid medium as described above.

  It is described as 1 / 50,000 (1: 50,000) Q efficacy (Q means 1 / 50,000, Quinquagintamillesimal), and is also described as "LM efficacy" in Roman numerals. In practice, the use of this Roman numeral is incorrect (LM is actually 950, not 50,000).

  The term "shake" means to shake vigorously the diluted homeopathic preparation to activate the drug.

  Grinding is the name of a procedure that grinds and reduces the particle size of a substance with a mortar and bowl.

  The present invention relates to spastic cerebral palsy (spastic, hyptonic, athetoid), ataxia cerebral palsy, intellectual impairment, depression due to neurological disease, autism, down syndrome, overall developmental delay, developmental disorder, neuropathy, brain injury , Neurometabolic disorders, stroke, attention deficit disorder, attention deficit hyperactivity disorder, apela syndrome, cleft encephalopathy, congenital cerebral malformation such as gyrus hypertrophy, porencephalythmia, dystonia, familial mental retardation, infantile hemiplegia, Nuclear jaundice, learning disorder, multiple cerebral infarction dementia, microcephaly, metabolic abnormality with neurological complication, postmeningoencephalitis brain injury, Rubinstein-Teibi syndrome, Rett syndrome, postoperative neuropathy, multiple sclerosis Syndrome, subacute sclerosing panencephalitis, and Lee's encephalopathy, Cornelia de Lange's syndrome, Japanese encephalitis, nodular sclerosis, cerebral leukotrilosis, chromosomal abnormalities, corpus callosum defect, various syndromes such as spinocerebellar syndrome, Developmental disorders, Including neurological disorders, but exposes the combination of therapeutic homeopathic drugs neurologic abnormalities and conditions which are not limited thereto.

  The present invention is also efficacious in mental conditions and reduces mental depression. Furthermore, the invention enhances the texture of the skin. Improvement is also seen in hereditary diseases and metabolic disorders.

The present invention relates to a formulation for the treatment of neurological diseases which comprises the following ingredients, together with a physiologically acceptable carrier:

At least one selected from the first group containing onion (Allium cepa), Arnica montana (Arnica montana), daisies (Bellis perennis), calendula (Calendula officinalis), Sturgeon (Hypericum perforatum), and phosphoric acid (Phosphoricum acidum) component

Aconitum (Aconitum napellus), Alumina (Alumina), Peyote Cactus (Anahalonium lewini), Silver Nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenide trioxide (Arsenicum album), Belladonna (Belladonna), Blue Khosh (Caulophyllum thalictroides), Causticum, Causticum, Cocculus indicus, Poisonous Ginseng (Conium maculatum), Copper (Cuprum metallicum), Curare, Curuka, Dulcamara, Red Ant (Formica rufa), Carolina Jasmin (Gelsemium sempervirens), Hypericum perforatum, potassium iodide (Kalium iodatum), potassium tartaricum (Kalium tartaricum), American rhubarb (Kalmia latifolia), bushmaster (Lachesis mutus), glass bean (Lathyrus sativus) Latrodectus hasselti), manganese acetate Tate (Manganum aceticum), mercuric chloride (Mercurius corrosivus), matin (Nux vomica), oxalic acid (Oxalicum acidum), white phosphorus (Phosphorus), carabalu bean (Physostigma venenosum), picric acid (Picricum acidum), plumbiacetate At least one selected from the second group containing (Plumbum aceticum), poison (Rhus toxicodendron), ergot (Secale cornutum), strykininpurum (Strychninum purum), thallium (Thaelium metallicum), and thoroidinum (Thyroidinum) component

Silver nitrate (Argentum nitricum), atropine (Atropinum), aurum metallicum (Aurum metallicum), barium carbonate (Baryta carbonica), Belladonna (Belladonna), oyster shell nacre (Calcarea carbonica), potassium hydroxide (Causticum), Greater selandin (Chelidonium majus), rattlefish snake (Crotalus horridus), yellow jasmine (Gelsemium sempervirens), blue sweet pea (Lathyrus sativus), lycopodium clavatum, martin (Nux vomica), oxalic acid (Oxalicumum) Containing (Phosphorus), Calabar (Physostigma venenosum), Lead (Plumbum metallicum), Crystal (Slicea terra), Strychninum purum, Sulfur (Sulphur), Tarantula (Tarentula hispanica), and Thuja occidentalis At least one component selected from three groups

From the fourth group that contains barium carbonate (Baryta carbonica), oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), potassium hydroxide (Causticum), sodium chloride (Natrium muriaticum), and crystal (Silicea terra) Selected at least one ingredient

Mugwort (Absinthium), aconit (Aconitum napellus), dog parsley (Aethusa cynapium), Amaranth (Agnus castus), aluminum (Alumina), ambragricia (Ambra grisea), marking nut (Anacardium orientale), aurora cactus (Anhalonium) lewinii), silver nitrate (Argentum nitricum), arnica montana (Arnica montana), gold (Aurum metallicum), neem (Azadirachta indica), barium carbonate (Baryta carbonica), marigold (Calendula officinalis), pearl layer of oyster shell ( Calcarea carbonica, calcium phosphate (Calcarea phosphorica), camphora officinalis (Camphora officinalis), Indian cannabis (Cannabis indica), plant charcoal (Carbo vegitabilis), Tussock ginseng (Cocculus indicus), poisonous ginseng (Conium maculatum), glycerin (Glycerinum) ), Ifthyol (Ichthyolum), potassium bromide (Kalium Bromatum), potassium carbonate (Kalium carbonicum), potassium phosphate (Kalium phosphoricum), dog's milk (Lac caninu), bushmaster (Lachesis mutus), lecithin (Lecithinum), hinocangula (Lycopodium clavatum), gonorrhea Medorrhinum), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), sodium carbonate (Natrium carbonicum), sodium chloride (Natrium muriaticum), nitric acid (Nitricum acidum), nutmeg (Nux moschata), matin (Nux vomica), ole Under = 夾 桃 (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), lead (Plumicum metallicum), rhodedendron (Rhododendron chrysanthum) Poison ivy and poison oak (Rhus toxicodendron), selenium (Selenium metallicum), Europe Squid squid (Sepia officinalis), crystal (Silicea terra), sulfur (Sulphur), rigid lower exudate (Syphilinum) of patients with syphilis, tellurium (Tellurium metallicum), thyroidinum (Thyroidinum), zinc (Zincum metallicum), zincic acid (Zincum) phosphoricum, at least one component selected from the fifth group containing zinc picrate (Zincum picricum)

Ohio Horse Chestnut (Aesculus glabra), Agaricus muscarius (Agaricus muscarius), Marking Nut (Anacardium orientale), Ubatama Cactus (Anhalonium lewinii), Atropininum (Atropninum), Barium Carbonate (Baryta carbonica), Belladonna (Belladonna), Hellopus luciferus ), Bovista licoperdon (Bovista lycoperdon), European toad (Buforana), cannabis (Cannabis indica), hemp (Cannabis sativa), potassium hydroxide (Causticum), cereus serpentinus (Cereus serpentinus), doxcilli (Cicuta virosa) ), Copper (Cuprum metallicum), Yellow jasmine (Gelsemium sempervirens), Hyos (Hyoscyamus niger), Ignatius beans (Ignatia amara), Potassium bromide (Kalium bromatum), Potassium cyanide (Kalium cyanatum), Bushmaster (Lachesis mutus), Bacchi Arhus (Laurocerasus), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), South African pink toe (Mygale lasiodora), Indian cobra (Naja tripudians), sodium chloride (Natrium muriaticum), nutmeg (Nux moschata), oleander = Containing Peach bamboo peach (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), white phosphorus (Phosphorus), chrysanthemum (Stramonium), sulphonalum (Sulfonalum), black-and-white sorrel (Thuja occidentalis), and the European goldfish (Vipera berus) At least one component selected from six groups

Dog parsley (Aethusa cynapium), Sambusia nirvana (Ailanthus glandulosa), alfalfa (Alfalfa), marking nut (Anacardium orientale), Ubata cactus (Anhalonium lewinii), silver nitrate (Argentum nitricum), oat (Avena sativa), Wild indigo , Oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), coca (Coca-Erythroxylon coca), clover (Cocculus indicus), copper (Cuprum metallicum), yellow jasmine (Gelsemium sempervirens), potassium bromide (Kalium) Bromatum), potassium phosphate (Kalium phosphoricum), lecithin (Lecithinum), sodium chloride (Natrium muriaticum), matin (Nux vomica), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), (Silicea terra), strychnine neric acid (Stychninum phosphori (cum), zinc (Zincum metallicum), zinc acid (Zincum phosphoricum), zinc picrate (Zincum picricum) at least one component selected from the seventh group containing

Belladonna (Belladonna), Toad Toad (Buforana), Spanish moth (Cantharis vesicatoria), Copper (Cuprum metallicum), Hyos (Hyoscyamus niger), Tiger Lily (Lilium tigrinum), Ercorn (Secale cornutum), Chosen Asagao (Stramonium) At least one component selected from the eighth group containing Tarantula (Tarentula hispanica), Veratrum album, and

Horse mackerel (Aconitum napellus), Agaricus muscarius (Agaricus muscarius), Bee (Apis mellifica), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenic trioxide (Arsenicum album), atropine (Atropinum), veradonna (Atropinum) Belladonna), benzoicum acidum, oyster shell nacre (Calcarea carbonica), spanish salmon (Cantharis vesicatoria), potassium hydroxide (Causticum), dokuseri (Cicuta virosa), American ginger (Cimicifuga racemosa), Sina Maritina (Cina maritima), Poisonous Ginseng (Conium maculatum), Woody Nightshade (Dulcamara), Toxa (Equisetum hyemale), Eryngium aquaticum (Eryngium aquaticum), Bone Set (Eupatorium perfoliatum), Joe Pi Suites (Eupatorium purpureum) ), Iron (Ferrum metallicum), iron phosphate (Ferrum) phosphoricum, yellow jasmine (Gelsemium sempervirens), hydrangea (Hydrangea arborescens), hyos (Hyoscyamus niger), potassium bromide (Kalium bromatum), potassium nitrate (Kalium nitricum), potassium phosphate (Kalium phosphorousum), cleosome (Kreosotum) ), Liana vulgaris, lupulus humulus, lycopodium clavatum, magnesium phosphate (Magnasia phosphorica), gonorrhea (Medorrhinum), matin (Nux vomica), poppy (Opium-Papaver omnium) Petroleum (Petroleum), Phosphoric acid (Phosphoricum acidum), Calaba bean (Physostigma venenosum), Horseradish (Plantago major), Horsetail (Pulsatilla pratensis), Rhushi (Rhus aromatica), Poison Ivy and Poisoned Oak (Rhus nicotinose) Sabal serrulata), Sanuki in Ottawa Cretaceous water (Sanicula aqua), Santonin (Santoninum), Ercorn (Secale cornutum), Senega (Senega), Eurasian Squid (Sepia officinalis), Crystal (Silica terra), Ginseng (Stramonium), Sulfur (Sulphur), Tv oil (Terebinthiniae oleum), Thyroidinum, Thuja occidentalis, Triticum repens-Agropyrum repens, Tuberculinum bovinum Kent, Uranium nitrate (Uranium niutilus) And at least one component selected from the ninth group containing zinc (Zincum metallicum)

  In general, the preparation is effective for treating neurological diseases in humans and may also be effective for treating neurological diseases in animals.

  Usually, this ingredient is a tincture.

  It is preferable that each component is fortified.

  The ingredients are usually aqueous extracts.

  It is desirable that the component is an ethanol solution.

  In general, the ingredients have all of X, C and LM potency from tincture, and preferably about 30 C to 1 M.

  Usually, the efficacy is either X efficacy or C efficacy.

  Generally, the physiologically acceptable carrier is selected from the group consisting of whey, sucrose, calcium carbonate, microcrystalline cellulose, carbon, carnauba wax, croscarmellose sodium, stearic acid, magnesium stearate, silicon dioxide, ethanol Be done.

According to a preferred embodiment of the present invention, there is provided a preparation for treating a neurological disease comprising the following ingredients together with a physiologically acceptable carrier.

i. Arnica montana
ii. Hypericum perforatum
iii. Causticum
iv. Hyos (Hyoscyamus niger)
v. Zinc acid (Zincum phosphoricum)
vi. Sodium chloride (Natrium muriaticum)
vii. Calcium phosphate (Calcarea phosphorica)
viii. Potassium phosphate (Kalium phosphoricum) and
ix. Iron phosphate (Ferrum phosphoricum)

  According to another preferred embodiment of the present invention, daisies (Bellis perennis) having efficacy of 30 C to 1 M, oyster shell nacre (Calcarea carbonica), alfalfa (Alfalfa) together with a physiologically acceptable carrier The present invention provides a preparation comprising oat (Avena sativa), zinc (Zincum metallicum), Sasamon (Stramonium), Causticum (Causticum), sodium chloride (Natrium muriaticum), potassium phosphate (Kalium phosphoricum).

  Usually, the amount of each component of the group has a width of about 1: 1 to 1:10 relative to the contents of the other groups.

  In general, the preparation is in a form selected from the group consisting of tablets, capsules, powders, globules, lozenges, pills, pellets, solutions, syrups, elixirs, suspensions, emulsions.

According to yet another aspect of the present invention, there is provided a method of formulating neurological disease treatment, comprising the following procedure.
i) Selection at least one component from the first group above at least one component from the second group above at least one component from the third group above at least one component from the fourth group above at least one component from the fifth group above At least one component from the sixth group At least one component from the above seventh group At least one component from the above eighth group At least one component from the above ninth group

ii) making a mixture containing the selected components in a ratio of about 1: 1 to 1:10 with respect to the other group

iii) Dilute the mixture with a liquid carrier selected from water or ethanol to obtain a potent mixture of tincture and LM potency or higher, possibly in the range of 30 C to 1 M

iv) Immerse the carrier globule in the dilution mixture to obtain the formulation

  In yet another embodiment of the present invention, the selective components in a ratio of 1: 1 to 1:10 relative to the other group are first enhanced in a homeopathic flow with a liquid carrier selected from water or ethanol, tincture and LM The potency during efficacy, preferably from 30 C to 1 M, is mixed and dipped in a carrier globule to obtain the formulation.

  Usually, the carrier globule is sucrose globule or lactose globule.

In yet another aspect of the invention, a method for treating neurological disorders in a subject, administering a dose of the formulation comprising an extract from: The above described approaches are presented.

At least one selected from the first group containing onion (Allium cepa), Arnica montana (Arnica montana), daisies (Bellis perennis), calendula (Calendula officinalis), Sturgeon (Hypericum perforatum), and phosphoric acid (Phosphoricum acidum) component

Aconitum (Aconitum napellus), Alumina (Alumina), Peyote Cactus (Anahalonium lewini), Silver Nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenide trioxide (Arsenicum album), Belladonna (Belladonna), Blue Khosh (Caulophyllum thalictroides), Causticum, Causticum, Cocculus indicus, Poisonous Ginseng (Conium maculatum), Copper (Cuprum metallicum), Curare, Curuka, Dulcamara, Red Ant (Formica rufa), Carolina Jasmin (Gelsemium sempervirens), Hypericum perforatum, potassium iodide (Kalium iodatum), potassium tartaricum (Kalium tartaricum), American rhubarb (Kalmia latifolia), bushmaster (Lachesis mutus), glass bean (Lathyrus sativus) Latrodectus hasselti), manganese acetate Tate (Manganum aceticum), mercuric chloride (Mercurius corrosivus), matin (Nux vomica), oxalic acid (Oxalicum acidum), white phosphorus (Phosphorus), carabalu bean (Physostigma venenosum), picric acid (Picricum acidum), plumbiacetate At least one selected from the second group containing (Plumbum aceticum), poison (Rhus toxicodendron), ergot (Secale cornutum), strykininpurum (Strychninum purum), thallium (Thaelium metallicum), and thoroidinum (Thyroidinum) component

Silver nitrate (Argentum nitricum), atropine (Atropinum), aurum metallicum (Aurum metallicum), barium carbonate (Baryta carbonica), Belladonna (Belladonna), oyster shell nacre (Calcarea carbonica), potassium hydroxide (Causticum), Greater selandin (Chelidonium majus), rattlefish snake (Crotalus horridus), yellow jasmine (Gelsemium sempervirens), blue sweet pea (Lathyrus sativus), lycopodium clavatum, martin (Nux vomica), oxalic acid (Oxalicumum) Containing (Phosphorus), Calabar (Physostigma venenosum), Lead (Plumbum metallicum), Crystal (Slicea terra), Strychninum purum, Sulfur (Sulphur), Tarantula (Tarentula hispanica), and Thuja occidentalis At least one component selected from three groups

From the fourth group that contains barium carbonate (Baryta carbonica), oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), potassium hydroxide (Causticum), sodium chloride (Natrium muriaticum), and crystal (Silicea terra) Selected at least one ingredient

Mugwort (Absinthium), aconit (Aconitum napellus), dog parsley (Aethusa cynapium), Amaranth (Agnus castus), aluminum (Alumina), ambragricia (Ambra grisea), marking nut (Anacardium orientale), aurora cactus (Anhalonium) lewinii), silver nitrate (Argentum nitricum), arnica montana (Arnica montana), gold (Aurum metallicum), neem (Azadirachta indica), barium carbonate (Baryta carbonica), marigold (Calendula officinalis), pearl layer of oyster shell ( Calcarea carbonica, calcium phosphate (Calcarea phosphorica), camphora officinalis (Camphora officinalis), Indian cannabis (Cannabis indica), plant charcoal (Carbo vegitabilis), Tussock ginseng (Cocculus indicus), poisonous ginseng (Conium maculatum), glycerin (Glycerinum) ), Ifthyol (Ichthyolum), potassium bromide (Kalium Bromatum), potassium carbonate (Kalium carbonicum), potassium phosphate (Kalium phosphoricum), dog's milk (Lac caninu), bushmaster (Lachesis mutus), lecithin (Lecithinum), hinocangula (Lycopodium clavatum), gonorrhea Medorrhinum), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), sodium carbonate (Natrium carbonicum), sodium chloride (Natrium muriaticum), nitric acid (Nitricum acidum), nutmeg (Nux moschata), matin (Nux vomica), ole Under = 夾 桃 (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), lead (Plumicum metallicum), rhodedendron (Rhododendron chrysanthum) Poison ivy and poison oak (Rhus toxicodendron), selenium (Selenium metallicum), Europe Squid squid (Sepia officinalis), crystal (Silicea terra), sulfur (Sulphur), rigid lower exudate (Syphilinum) of patients with syphilis, tellurium (Tellurium metallicum), thyroidinum (Thyroidinum), zinc (Zincum metallicum), zincic acid (Zincum) phosphoricum, at least one component selected from the fifth group containing zinc picrate (Zincum picricum)

Ohio Horse Chestnut (Aesculus glabra), Agaricus muscarius (Agaricus muscarius), Marking Nut (Anacardium orientale), Ubatama Cactus (Anhalonium lewinii), Atropininum, Barium Carbonate (Baryta carbonica), Belladonna (Belladonna), Bacillus Chirocerus ), Bovista licoperdon (Bovista lycoperdon), European toad (Buforana), cannabis (Cannabis indica), hemp (Cannabis sativa), potassium hydroxide (Causticum), cereus serpentinus (Cereus serpentinus), doxcilli (Cicuta virosa) ), Copper (Cuprum metallicum), Yellow jasmine (Gelsemium sempervirens), Hyos (Hyoscyamus niger), Ignatius beans (Ignatia amara), Potassium bromide (Kalium bromatum), Potassium cyanide (Kalium cyanatum), Bushmaster (Lachesis mutus), Bacchi Ki (Laurocerasus), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), South African pink toe (Mygale lasiodora), Indian cobra (Naja tripudians), sodium chloride (Natrium muriaticum), nutmeg (Nux moschata), oleander = Containing No. bamboo peach (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), white phosphorus (Phosphorus), chrysanthemum (Stramonium), Sulfonalum (Sulfonalum), European sturgeon (Thuja occidentalis), and the European snapper (Vipera berus) At least one component selected from six groups

Dog parsley (Aethusa cynapium), Sambusia nirvana (Ailanthus glandulosa), alfalfa (Alfalfa), marking nut (Anacardium orientale), Ubata cactus (Anhalonium lewinii), silver nitrate (Argentum nitricum), oat (Avena sativa), Wild indigo , Oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), coca (Coca-Erythroxylon coca), clover (Cocculus indicus), copper (Cuprum metallicum), yellow jasmine (Gelsemium sempervirens), potassium bromide (Kalium) Bromatum), potassium phosphate (Kalium phosphoricum), lecithin (Lecithinum), sodium chloride (Natrium muriaticum), matin (Nux vomica), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), (Silicea terra), strychnine neric acid (Stychninum phosphori (cum), zinc (Zincum metallicum), zinc acid (Zincum phosphoricum), zinc picrate (Zincum picricum) at least one component selected from the seventh group containing

Belladonna (Belladonna), Toad Toad (Buforana), Spanish moth (Cantharis vesicatoria), Copper (Cuprum metallicum), Hyos (Hyoscyamus niger), Tiger Lily (Lilium tigrinum), Ercorn (Secale cornutum), Chosen Asagao (Stramonium) At least one component selected from the eighth group containing Tarantula (Tarentula hispanica), Veratrum album, and

Horse mackerel (Aconitum napellus), Agaricus muscarius (Agaricus muscarius), Bee (Apis mellifica), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenic trioxide (Arsenicum album), atropine (Atropinum), veradonna (Atropinum) Belladonna), benzoicum acidum, oyster shell nacre (Calcarea carbonica), spanish salmon (Cantharis vesicatoria), potassium hydroxide (Causticum), dokuseri (Cicuta virosa), American ginger (Cimicifuga racemosa), Sina Maritina (Cina maritima), Poisonous Ginseng (Conium maculatum), Woody Nightshade (Dulcamara), Toxa (Equisetum hyemale), Eryngium aquaticum (Eryngium aquaticum), Bone Set (Eupatorium perfoliatum), Joe Pi Suites (Eupatorium purpureum) ), Iron (Ferrum metallicum), iron phosphate (Ferrum) phosphoricum, yellow jasmine (Gelsemium sempervirens), hydrangea (Hydrangea arborescens), hyos (Hyoscyamus niger), potassium bromide (Kalium bromatum), potassium nitrate (Kalium nitricum), potassium phosphate (Kalium phosphorousum), cleosome (Kreosotum) ), Liana vulgaris, lupulus humulus, lycopodium clavatum, magnesium phosphate (Magnasia phosphorica), gonorrhea (Medorrhinum), matin (Nux vomica), poppy (Opium-Papaver omnium) Petroleum (Petroleum), Phosphoric acid (Phosphoricum acidum), Calaba bean (Physostigma venenosum), Horseradish (Plantago major), Horsetail (Pulsatilla pratensis), Rhushi (Rhus aromatica), Poison Ivy and Poisoned Oak (Rhus nicotinose) Sabal serrulata), Sanuki in Ottawa Cretaceous water (Sanicula aqua), Santonin (Santoninum), Ercorn (Secale cornutum), Senega (Senega), Eurasian Squid (Sepia officinalis), Crystal (Silica terra), Ginseng (Stramonium), Sulfur (Sulphur), Tv oil (Terebinthiniae oleum), Thyroidinum, Thuja occidentalis, Scutellariae Triticum repens-Agropyrum repens, Tuberculinum bovinum Kent, Uranium nitrate And at least one component selected from the ninth group containing zinc (Zincum metallicum)

  Usually, the components released in the first group act in the nervous system to assist in the healing process of neuritis such as nerve injury and traumatic disease.

  Usually, the components released in the second group act in the nervous system to assist in the healing process of paraplegia.

  Usually, the components released in the third group act in the nervous system and aid the healing process of degeneration such as multiple sclerosis.

  Usually, the components released in the fourth group act in the motor system and result in the improvement of walking, especially in children who have a slow onset of walking.

  Usually, the components released in the fifth group act on the mind and enhance memory. There is an auxiliary action to recover lost memory.

  Usually, the components released in the sixth group act on the mind and enhance the ability to speak. In particular, the administration of the extract of this ingredient cures the delay, difficulty, ambiguity and stuttering of the utterance.

  Usually, the components released in the seventh group act on the mind and release mental fatigue.

  In general, the ingredients released in the eighth group act on the mind and are found in many patients to suppress phlegm, such as destructive, biting, hitting, and tearing the cloth.

  In general, the components released in the ninth group act on the urinary system to cure enuresis or incontinence, and are generally used as therapeutic agents.

  Invention formulations are formulated by adding different component diluents in a fixed amount, usually in an amount ready to use in tablets or globules made from lactose or sucrose. Preferably, dilutions of homeopathic ingredients are added until the tablet is sufficiently wet. There are tablets of various sizes. The dispensing procedure is described in detail below.

  It is preferable to prepare a bottle with a harmless plastic cap as a clean, dust free reaction mixer. Pour boiling water into it and let the air escape completely. After about 5 minutes, discard the hot water and air dry the bottle completely. Keep sterile during work. Or, the bottle is sterilized by high pressure steam sterilization.

  In a clean, dust-free, odor-free environment, pour predetermined amounts of each of the fortifying components from each container into a bottle. Once each component is added, cap the bottle tightly and shake for 5 to 15 minutes with your hand or other existing means so that a homeopathic mixture is formed.

  In another reaction vessel (bottle), put sterile sugar globules up to 3/4 volume of the vessel. The homeopathic mixture of ingredients is poured slowly and evenly so as not to splash until the liquid has completely soaked the globule. The globule is ready for dispensing. Store the bottle in an airtight, cool, dark, odorless environment and away from direct sunlight and electromagnetic radiation.

  One of the preferred combinations of the present invention is herbal ingredients and non-herbal ingredients of about 200 C potency.

  The homeopathic ingredients of the present invention are non-toxic and do not cause undesirable side effects. Each component is also included in major homeopathic pharmacopoeias, such as the US homeopathic pharmacopoeia and the Indian homeopathic pharmacopoeia. Zinc, hyos, etc., which are part of the components of the present invention, have been used for centuries in Ayurvedic.

  According to a preferred embodiment of the present invention, the homeopathic formulation is in various administrations, including oral, topical, parenteral and other new systems.

  Oral administration is the preferred formulation administration method of the present invention. Homeopathic formulation active ingredients are orally acceptable combinations with sugar tablets, tablets, drops, pills, water, glycerin, lactose, sugar cane, alcohol, medicinal powders, medicinal globules (pellets, pellets), corn etc. Used in homeopathic standard dosing systems.

  The active ingredient of the homeopathic preparation is administered by inhalation, topical application to the skin, parenterally such as intravenous injection, or other homeopathic manner such as intramuscular, intradermal, intravenous, subcutaneous injection, or herbal or inverse symptom administration methods Sometimes. Other administration methods include implantation of a pump and other devices into the body for administration, and administration systems applied by modern medicine, biotechnology, nanotechnology, and the like. The preparation is also administered intranasally, eye drops, ear drops, or suppositories, patches or the like. For each of the different modes of administration, it is premised that the formulation is formulated with appropriate efficacy and proceeds on a safe and effective basis as described in OTC, HPUS and other medical literature.

  Usually, three pills are given in the morning or in the evening, although the dose or dose is relatively unimportant. It is desirable that the mouth and tongue be clean and odorless so that the formulation is maximally absorbed and effective. Usually, three pills are initially taken from the bottle to the cap of the bottle or from other harmless containers. At this time, it is desirable not to touch the pill with hands. Then put the pill in your mouth and bite until it melts. Because the drug is absorbed under the tongue, it is desirable to refrain from eating and drinking for 30 minutes before and after taking the drug of the present invention. In order to maximize the effect, it is preferable to avoid non-vegetable foods, coffee, foods with strong odors such as fresh onions and garlic. However, it is recommended to obtain the significant efficacy of the invention in the unique combination mentioned in the formulation. The formulation of the present invention can also be given as an auxiliary role for other drugs and rehabilitation.

  Mechanism of action of the preparation

  In the case of homeopathy, highly diluted compounds are believed to be biologically active in cells in an electromagnetic field (Benveniste, 1993, Frontier Perspec. 3 (2): 13-15). Furthermore, in the case of homeopathy, the interaction between the electric dipole of the water and the radiation field of the charged molecules causes permanent polarization of the water, which allows it to be phased out and send special information to the cell receptor, Del Giudice et al. (Del Giudice, E., Preparata, G., Vitiello, G., 1988, Phys. Rev. Lett. 61: 1085-1088). The benefits of homeopathic remedies are well documented and have become a very popular factor worldwide.

  Based on the patient observations described in the latter part of the specification, the possibility of acting on neurotransmitters and nerve growth factors can be shown. In addition, it has been hypothesized that the minerals of the present invention reactivate chemical changes in neurotransmission while the herbal extract is a catalyst to promote improvement. Presumably, the present invention eliminates synapse level disorders or promotes myelination.

  None of the individual components of the invention are described as having a curative effect on certain neurological diseases such as cerebral palsy, intellectual disability, autism and the like. Thus, the present invention having broad utility for various neurological diseases is said to be special. The formulations of the present invention do not require the discovery of an allotherapeutic agent (the most similar therapy to the patient's condition) or even casework diagnostics that attempt to indicate correct efficacy, persistence, and dosage. Thus, the present invention is a common formulation for several of the above neurological diseases and does not require individualization of drugs using a single drug component per dose, as has been done in conventional homeopathy. . According to the standard homeopathic pharmacopoeia all components of the invention are complementary, the individual elements being applied in homeopathy and used for many years in Ayurvedic.

  While the previous preferred embodiments may provide the best results for the above-mentioned neurological disorders, it is expected that the various other preferred formulations of the present invention also have superior therapeutic properties. The homeopathic formulations of the present invention may vary in terms of potency, dosage, or ingredients. The homeopathic preparation of the present invention can be administered either alcohol or non-alcohol. Each component of the formulation of the present invention may be given with various efficacy, such as low efficacy such as tincture to 50 m, high efficacy of LM or higher. Preferred homeopathic formulations of the present invention are made of nine different components. Some formulations of the invention can also be made without the use of one or more of the nine components. Even if one or several of the nine components are omitted from the formulation, the formulation still has effective properties. The homeopathic preparation of the present invention can also be composed of eight components, seven components, six components, and five components. However, if one component is removed from the nine components, the effectiveness obtained with all the components gradually decreases.

  The formulations of the present invention can be combined with other therapies or substances, such as allopathic remedies, vitamins, minerals, amino acids, conventional homeopathic remedies, inactive substances. The individual components can also be provided in reinforced form or in other forms such as, but not limited to, mother liquor, biotechnology, nanotechnology and the like.

  The individual components of the therapy can be administered simultaneously at the same time or in various orders and combinations. For example, several components can be administered together and the remainder can be administered separately. Additional ingredients can be added to the treatment if it enhances efficacy or if it functions at the same level of efficacy.

  The invention will be described in the following examples, which do not limit the scope of the invention.

Arnica montana (Arnica montana), Sturgeon (Hypericum perforatum), causticum (Causticum), hyos (Hyoscyamus niger), zincic acid (Zincum phosphoricum), sodium chloride (Natrium muriaticum), calcium phosphate (Calcarea phosphorica), potassium phosphate ( A fortified preparation of Kalium phosphoricum) and iron phosphate (Ferrum phosphoricum) was obtained. These nine components were at a potency of 30 C to 1 M. First, the nine components were mixed into the homeopathic flow described above and the resulting mixture was added to sucrose globule to soak the globule in liquid. It is preferred to soak until the globule is sufficiently wet. The fortified formulation was formulated at repeated dilutions according to standard homeopathic procedures.

  The generated combination preparation of the present invention was administered to 29 patients suffering from various neurological diseases. Details about the results and the patients administered will be described in the following cases. Patients were observed on video whenever possible. Record improvement options by therapists and parents. Studies of nerve conduction velocity (NCV) were performed as much as possible before and after treatment.

  Prior to receiving the treatment of the present invention, all patients received conventional treatments such as occupational therapy, speech therapy, symptomatic drug treatment and the like. The response after the treatment administration of the present invention was clearly improved over that of the conventional treatment described above, and the effectiveness of the present invention was shown. No side effects were seen in any patient. Details of the improvement seen after the administration of the invention will now be described.

  Case study

  Patient 1 A 5-year-old boy suffering from spastic biplegia-type cerebral palsy was born prematurely at 7 months and was a 1.1 kg low birth weight child. He complained of motor development index delay, partial bowel and bladder control. When the treatment of the present invention was continued for two months, shedding was reduced, and the habit of hitting my face with my own hand was slightly reduced. At the third month, tension in the hips decreased. After 6 months of administration, the lateral progression improved and began to show interest in learning.

  Patient 2 A 7-year-old girl with microcephaly with postmeningitis mental retardation, verbal retardation, and autistic signs has short sleep, self-harm, self-stimulating behavior, excitability, no crying, hope , Come to the hospital for complaints that the bowel and bladder control can not be performed. At the second month of the treatment of the present invention, sleep was improved and the head circumference was enlarged by 1 cm. Furthermore, their understanding and understanding have improved. By the fourth month of treatment, sleep was further improved, eating skills were improved, and chapati (Indian bread) were also eaten when given little by little. Self-injury also decreased. At six months, I started to keep my eyes on it, and I started to eat myself most of the time. In the 10th month, I started to speak meaningless words and started to get out of the building on my own. After 10 months of treatment, her voice improved greatly, the excitement subsided relatively, and she became a little more accustomed to her mother.

  Patient 39 A 9-year-old girl suffered from microcephaly and was associated with mental retardation and delayed developmental indicators. It was late to raise her voice and was a 1.2 kg low birth weight baby. According to the patient's electroencephalogram, symptoms of bilateral central temporal epileptiform activity were observed, particularly the right side was stronger than the left side. The patient had never received any seizure control medication. He came to the hospital with a complaint that he can only hear the voice of "Abba (meaning father in Indian words)" when his walking is not well balanced. In just one month, it became clearer, it became more understandable, it was less drooling, its frequency of falling was reduced, and its head circumference expanded from 43.8 cm to 44 cm. After three months of treatment, the balance is much better, you can climb stairs several steps without assistance, you can eat relatively cleanly, bite food firmly, get water out of your mouth when you brush your teeth I started. After six months of treatment, her motor and cognitive functions improved significantly, and she began to understand Marathi, a local language that she did not understand before. In addition, she began to dance well at school, got rid of her clothes, and began to be able to distinguish her belongings from those of others.

  Patient 4 A 6-year-old girl with Attention Deficit Hyperactivity Disorder was a close relative. Visited with complaints of intellectual disability and hyperactivity. After one month of treatment, my understanding improved and I began to listen to what I said. It was scheduled for 4 months, but it was interrupted for 1 month due to a cold and cough. Despite discontinuation of treatment, brushing skills improved and color ideas improved. After two months of treatment I became more comprehensible, began to recognize the illustrations in the book, grasped the pencil firmly and began to write some Arabic letters. However, hyperactivity continued without change.

  Patient 5 The 8-year-old boy in the low-income group suffered from microcephaly, attention deficit hyperactivity disorder, and speech delay. The patient also had behavioral problems. In the first month of treatment, hyperactivity decreased, she began to speak a few words, said her name, and she became less excited about comprehension. In the third month of treatment, hyperactivity was further reduced, speech improved and clearer, the ability to wear clothes alone increased slightly, and comprehension further increased. At 5 months of treatment, it was found that the head circumference had expanded from 45.5 cm to 45.7 cm. I started to talk in sentences composed of 2 or 3 words.

  Patient 6 A 9-year-old boy with attention deficit hyperactivity disorder, speech delay, and some signs of autism visits the hospital. I was obsessed with playing with plastic products such as plastic bags. It was a close relative. Although there was no problem with the birth history, it dropped from the bed at 6 to 8 months, and regression of the index began to occur after jerks. Peri-ventricular calcification was noted on the scan. By the fourth month of treatment, hyperactivity decreased and I was sitting in one place for 15 to 20 minutes, interest in polyethylene decreased, and I was trying to dress alone. . When I wanted to go to the bathroom, I came to tell my parents. By the fifth month of treatment, his facial expression improved, the aforementioned improvement contents were maintained, he brushed his teeth and began to take a bath. By the tenth month of treatment, the aforementioned improvements were maintained, and it became possible to follow simple instructions such as bringing a glass of water and taking a TV remote control.

  Patient 7 A 15-year-old boy diagnosed with spastic biplegia-type cerebral palsy was born prematurely at 7 months and was a 900 g low birth weight infant. There was a newborn baby jaundice. Visiting for complaint that walking is not successful and fine motor skills are low. After two months of treatment I was able to get a good balance when standing on my knees. At 4 months of treatment, it was noted that the extension of both hips became successful and at 7 months, they came to stand slightly.

  Patient 8 A 4-year-old girl diagnosed with right hemiplegia had no abnormalities in her birth history. When I came to the hospital, my speech was unclear and the movement on the right was bad. At the first month of treatment, his grip increased and he became a little more hilarious. At 4 months of treatment, the spasms were relieved, walking improved, and the hand function improved. By the fifth month, the patient's physiotherapist noticed that the condition was generally very good and he began to climb himself up in a 7-inch (17 cm) tall chair.

  Patient 9 A 14-year-old girl who was diagnosed with seizure disorder, right hemiplegia, and intellectual disability in a microcephaly, had a birth history of a low-weight child who was late to raise at term. After birth, jaundice appeared and after 3 months there was convulsions. Spasms were still present at intervals of 2-3 months. The scan showed moderate brain atrophy, and electroencephalography was abnormal. Motor development index delay, low academic ability, visit with complaint of weakness on the right. After six months of treatment, I was able to use my right hand and was able to grasp and release things. Comprehension increased, and at this age, the head circumference also expanded from 46 cm to 47 cm. Myoclonus reflex was reduced than before.

  Patient 10 A 4-year-old boy diagnosed with macrocephaly with hypotension and gross developmental delay had a birth history of lower cesarean section due to the size of his head at term delivery. The birth voice was raised normally. There was a history of neonatal jaundice. It was good for up to three months, but then myoclonus reflexes started. By six months, he became out of sight and began to lose social smiles. Nuclear magnetic resonance imaging (MRI) showed ventricular dilatation and abnormal EEG. The metabolic screening test was not a problem. He was admitted to the hospital for complaints about exercise, speech, mental development index delay, seizure disorder, and inability to control the bowel and bladder. "I am always trying to make fun. I am always trying to make fun. I hope that I can have a talk with everyone and have them play. ', Parents reported. In the fifth month of treatment, I became more active, began to recognize my parents and my grandparents, made continuous sounds, improved my ability to track objects visually, and when I let them sit I was able to keep balance better than before . I was also helped to improve my balance, emotional parts and comprehension when standing.

  Patient 11 A 57-year-old man with a history of palmamen semicircle numbness, right arm weakness and right forefinger joint deformity associated with low handgrip of both hands had had right shoulder pain 2.5 years ago. MRI of the neck with extensive spondyloarthritis: 1) Uncovertebral osteophytes, compression of the C6 right and C7 nerve roots, and degenerative spinal stenosis at these levels Bilateral occurrence of C5 / 6 interforaminal stenosis due to diffuse posterior disk osteophyte complexes. 2) Cervical compression myelopathy was not seen. Decompression surgery in December 2005. In the nerve conduction velocity examination before starting the treatment of the present invention, signs of motor neurodegeneration of both upper limbs (more serious on the right side) of the root muscles were seen at the anterior horn cell level. At the 4th month of treatment, pain in the right index finger is reduced. At 6 months of treatment, repeated examination of nerve conduction velocity showed improvement in motor activity between the biceps and dorsal bone. At nine months, grip strength has greatly improved. Considering the diagnostic results of anterior horn cell level injury, it is surprising that such improvement was seen after 6 months of treatment, and the neurotransmission rate test shows physical evidence of regeneration.

  Patient 12 A 3-year-old and 7-month-old boy diagnosed with Down syndrome complained of delayed speech development indicators, congenital heart disease, recurrence of cold and cough, and constant small amount of urine leak. A birth history of 1.5 kg low birth weight infants in normal birth (second child), signs of large ventricular septal defect in 2D echocardiography, developmental index delay (beginning to walk at 3 years). In the second month of treatment, I began to speak some of the words "Mama" and "Dadda", letters such as "A, B, C" and some Hindi alphabets at school. At the fourth month of treatment, his walking was well balanced and he tried to run. The understanding also increased by 60%. After 15 months of treatment, the frequency of cold and cough is reduced. The vocabulary increased and it became clear. Social exchange capacity has also been improved.

  Patient 13 A 2-year-old and 3-month-old girl diagnosed with spastic cerebral palsy with developmental delay mainly complains of a delay in movement and speech development indicators. Birth history of neonatal jaundice, early motor development index delay, sitting at 1 year, and normal electroencephalogram. After one month of treatment, he was able to stand for a few seconds without assistance. With the help, I could stand for about 30 minutes, and I increased non-verbal communication and understanding. In addition, I began to recognize cards of imitation and pictures of nursery rhymes. In the third month of treatment, I came to walk about 4 to 5 steps by myself and came to express that I wanted to go to the bathroom. Verbal and non-verbal communication skills have also improved. By the fifth month of treatment, it became possible to perform 10 to 15 steps of groin walk without assistance, and it became possible to stand from a sitting posture freely. He started to speak two or three words and was able to recognize parts of his body. By the eighth month of treatment, I was able to stand alone from the crouched posture, and I needed only minimal levels of brushing, bathing, and dietary assistance. The head circumference was expanded from 47 cm to 48 cm.

  Patient 14 A 4-year-old and 9-month-old boy who was diagnosed with microcephaly with cerebral palsy and spastic quadruplegia mainly complained of movement, speech, and mental development index delay. There was also a breath holding attack, partial bowel and bladder control. Maternal history of typhoid fever during pregnancy, patient with meconiun poisoning, birth asphyxia at birth with neonatal seizures. In the first month of treatment, the seizures have been reduced and the balance when sitting down has improved. At 4 months of treatment, breath holding attacks were further reduced. Head circumference expanded from 45.5 cm to 46 cm. The tension in the upper limbs was reduced, the understanding was improved, and the balance when sitting was improved.

  Patient 15 Eleven-month-old girl diagnosed with microcephaly with epilepsy, gross developmental delay, daily seizure, exercise, speech, mental developmental delay, cortical visual deficit, food Complaints of swallowing difficulties. The second of the twins was a temporary asphyxia at 1.4 kg, a low-weight infant. After one month of treatment, the patient's excitement is reduced. At 4 months of treatment, the jerks were reduced and the neck was more neutral. Improvements were seen at 5 months of treatment, with increased head circumference (37 cm to 37.5 cm), improved control of the neck, and increased vocalization. At 6 months of treatment, improvement in mental response, push-up posture and neck control improved. At nine months of treatment, she got a lot more sleep, better weight support for her lower extremities, and tried to turn from supine to prone position. After 16 months of treatment, the neck support improved, and when the name was called, the facial expressions became rich and seizures decreased.

  Patient 16 A 19-year-old boy diagnosed with familial mental retardation accompanied by a behavioral disorder complains of poor understanding, reading and writing skills, and a habit of biting a nail. As for the birth history, the patient's parents are close relatives, and the two sisters are in the same condition. The first month of treatment began to regulate the behavior. After 2 months of treatment, my sleep became deep and quiet.

  Patient 17 For a 7-year-old and 6-month-old boy who was diagnosed with signs of autism with Attention Deficit Hyperactivity Disorder, the chief complained of hyperactivity, delayed speech development indicators, seizure disorders, and an overweight barrier. Preterm birth at 33-36 weeks, 1.52 kg of low birth weight infant with neonatal convulsions. Computed tomography (CT) scan and EEG were both normal. At the third month of treatment, speech increased. Fourth month of treatment, she spoke new words and relieved overeating habits.

  Patient 18 A 10-year-old boy diagnosed with quadruple-legs after meningoencephalitis with extrapyramidal symptoms is unable to sit, stand or walk, regression index of speech milestones, and also bowel and bladder control I could not. The birth history was normal until seven years old. He had a history of chicken pox, vomiting and headache after viral encephalitis (septic shock, acute respiratory distress syndrome, hemorrhagic thalamus hemorrhagic thalami, hippocampus hippocampus). In the first month of treatment, my understanding increased, I tried to speak short sentences, and the balance when I sat with assistance improved. At the third month of treatment, his speech became clear, he was able to bite the food well, and he was trying to get up from a prone position. After 10 months of treatment, I could sit by myself from one side in the quadruped position, and the coordination from hand to mouth was improved. I was able to stand on the back of the wall and I became rich in expressions. Food intake has improved and understanding has improved.

  Patient 19 For a 5-year-old and 4-month-old boy who was diagnosed as having seizure disorder and developmental retardation, the chief exercise, speech, mental development index delay, bowel and bladder control not possible, left weakness, seizure disorder Appealed. A 2.3 kg low birth weight child born on cesarean section and had hypoglycemic convulsions at birth. EEG showed signs of underlying structural disease. After 4 months of treatment, the number of violent attacks decreased. With the help I was able to stand in a balanced manner and bladder control came to work well. His understanding has improved, and he has come to hear more of his talk in the language. At 6 months of treatment, food intake improved, he became more eye-growing, and he started to follow the instructions, increasing his speech in the rhetoric.

  Patient 20 A 3-year-old and 6-month-old girl diagnosed with dystonic quadriplegia and microcephaly with paroxysmal disease: exercise, speech, mental developmental delay, bowel and bladder control not possible, visual impairment, seizures Sexual complaints are the main complaint. First child, 18 months early birth history of preterm birth in emergency cesarean section. She was a newborn anoxia and a 1.8 kg low birth weight infant. A CT scan showed encephalomalacia near the back of the back of the head. EEG showed signs of intensive epilepsy near the left frontotemporal area. In the second month of treatment, the intestines and bladder began to be shown with sounds and gestures. You can now better support your weight on the forearm during visual tracking and prone position. At the 4th month of treatment, she was reduced in slippage, became aware of gestures, improved mental responses, and increased her ability to adapt to the environment.

  Patient 21 A 9-year-old and 7-month-old boy diagnosed with spastic cerebral palsy with familial mental retardation is a major complaint that she is unable to stand, walk on her own, and has poor academic ability. Patient's parents are close relatives, developmental delay family history positive. The skull is large from birth. I had a history of convulsions since 7 months. CT scans showed signs of severe fronto-temporal atrophy. In the second month of treatment, he began to walk with assistance and travel more frequently along the side of the bed. Communication became complete and effective, and bowel and bladder control became normal. At the eighth month of treatment, myotonic tone improved overall, I was able to communicate normally, and my comprehension increased. I often went along the side of my bed and started to change my clothes. At 11 months of treatment, muscle tone was further improved overall. I was able to come to a standing position with assistance, and I was able to immediately get up without assistance. Communication skills were further improved, and I felt that I was independent. I got to wear my shirt and pants myself. After 16 months of treatment, he was able to stand for a while without assistance, and also for 30 minutes continuously. Comprehension increased, and the calf circumference expanded from 6.8 inches to 7.1 inches (17.2 cm to 18 cm).

  Patient 22 A 5-year-old girl diagnosed with diplegic cerebral palsy and microcephaly with attention deficit hyperactivity disorder mainly has an imbalance during gait, unclear speech and excitability Sued. The second child, 17-year-old sister was in normal condition. I had a spasm at 5 months. In the posterior tibial somatosensory evoked potential test, somatosensory conduction in the central somato-sensory pathway showed signs of abnormalities on the left side rather than the right side. EEG confirmed signs of epileptiform abnormality near the right occipital region. At 2 months of treatment, the excitability subsided slightly. It was possible to stand immediately from sleeping and sitting postures, and it became possible to speak long sentences. I have improved my handwriting skills, now I can walk straight and I can release and release buttons. Walking balance improved at 4 months of treatment. I was able to go up and down the stairs without assistance, and started writing "A, B, C" or "1, 2, 3". In the 20th month, academics improved.

  Patient 23 A 5-year-old boy diagnosed with spastic biplegia-type cerebral palsy complained mainly of motor development index delay and unclear speech. The preterm birth at 30-32 weeks was a 1.5 kg low birth weight baby at birth. A patient with respiratory distress syndrome with neonatal jaundice who has been in the neonatal intensive care unit for 12 days. I started to sit at the age of 1.5 with development index delay. At 2 months of treatment, the balance improved and the speech became clear. After six months of treatment, my understanding, imagination and thinking improved and my balance improved.

  Patient 24 A 9-year-old boy diagnosed with athetoid cerebral palsy with right hemiplegia mainly complained of motor development index delay, unclear speech, involuntary movements, right side weakness. It has a birth history of neonatal anoxia, neonatal convulsions, jaundice due to childbirth (because the umbilical cord was caught around the neck). MRI showed signs of putaminal gliotic lesions. Improved balance when sitting at 5 months of treatment and improved walking using a walker. Utterances became clearer and were able to stand for 1-2 minutes without assistance. In addition, the eating rate also improved. The balance of sitting and standing at 7 months of treatment improved, and he was able to stand upright from 120 to 130 counts. At 16 months of treatment, involuntary movements decreased, the balance between sitting and standing became better, and it became possible to switch on and off the television.

  Patient 25 A 4-year-old boy who was diagnosed with overall developmental delay with propionic acidemia (prophylactic academia) mainly used speech and motor development index delay, no bowel and bladder control, no gaze, frequent lip contact Complaints. The patient was born on a caesarean section with her baby. It showed normal development for up to 4 months but then delayed (it started to sit at 1.5). It turns out that he is suffering from a metabolic disorder (propionic academia). Auditory sensitivity, visual evoked potential is normal. MRI showed signs of white matter high signal area, and EEG showed signs of multifocal epileptic focus. By the fifth month of treatment, I was able to sit on my own and tried to use the elbows to balance. In addition, he began to try to eat and eat food by himself and to take an attitude of crawling and crawling. He started to speak gently and began to say words like "Appa".

  Patient 26 A 4-year-old girl diagnosed with autism spectrum disorder with speech and language development index delay mainly complains of sleep disorder, constipation, gait difficulty, speech difficulty, shed in her own shell, etc. The second child, there is a sister in normal condition. He was born on a vaginal delivery (reciprocal), had neonatal anoxia and neonatal spasm, entered a neonatal intensive care unit for 15 days, and had a tracheostomy. VP shunt surgery was performed in 3 months and reoperation was performed at 9 months (infection). After 2 months of treatment, I got out of bed to urinate. In addition, they began to combine two words in a conversation, and began to imitate many new words. Interpersonal adaptability increases, understanding improves, and walking balance also improves. At the fourth month of treatment, he became able to follow instructions better than before, and his walking balance became even better.

  Patient 27 One-and-a-five-month-old boy who was diagnosed with post meningitis developmental delay was mainly motor development index delay, cortical visual deficit, right weakness, right hearing Complaint of loss. He has a birth history of neonatal cramps at 10 months and recurrence at 1.5 months. A CT scan showed signs of purulent meningitis with cerebral edema. MRI showed signs of delayed myelination, while auditory brainstem response showed signs of right hearing loss. At 3.5 months of treatment, it becomes possible to sit from the supine position on its own and move while moving the buttocks, and the head circumference is expanded from 41.5 cm to 42 cm, and it is attempted to stand with assistance, prone position It became possible to rotate. At the 5th month of treatment, the eye movement improves, so that you can speak a word in the rhetorical language, increase your understanding, expand your head circumference from 42 cm to 42.5 cm, so that you can move while taking your chair forward became. At 6 months of treatment, I can get a good eye gaze, take a pen from my father's pocket, play with toys, play socially well, follow instructions, speak out, floor I started to stand up from there. At 7 months, I get to keep my eyes tight and try to get things with my hands, move along the furniture, point out some parts of my body and say more words It became so. At the 12th month of treatment, the eye movement was further improved, and he became a four-legged posture on his own, stood with assistance, and his understanding increased.

  Patient 28 A 15-year-old boy who was diagnosed with Attention Deficit Hyperactivity Disorder, complained of poor comprehension, delayed language development indicators, and frequent (sometimes violent) complaints. It has a birth history of preterm birth at 7 months, low birth weight infants, delay with all developmental indicators (starting to walk at age 4 and talking at age 8), and signs of sickness. In the second month of treatment, I began to speak short sentences. At the third month of treatment, the excitement tended to subside, the height was reduced, the behavior improved, and the television watched the "Animal Kingdom" channel (previously not showing interest in television). At the seventh month of treatment, the excitement lasted for a short time, and at the time of the meal came to tell that it had finished eating.

  Patient 29 A 51-year-old woman who was diagnosed with speech disorder and cerebral palsy with spastic four-legs paralysis mainly complained of delay in physical and speech development indicators. After 18 months of treatment, he was able to draw pictures well while using the right hand partly by himself, and also to eat with the right hand partly by himself, resulting in deep sleep and improved contact.

Overview
Number of patients 29 male 18 female 11 age range 1 year 5 months to 57 years

  inspection result

  29 types of improvement types

  This result demonstrates that the present invention has a beneficial effect on exercise and higher mental function and significantly enhances the quality of life of patients suffering from neurological diseases.

  Similarly, the invention may have shown therapeutic effects on animals and other organisms suffering from neurological diseases.

  Technological advantages and economic importance

  The invention has several technical advantages and economic importance, as indicated below.

  The homeopathic preparation of the present invention is spastic cerebral palsy (spastic, hyptonic, athetoid), ataxia cerebral palsy, intellectual disability, depression due to neurological disease, autism, down syndrome, general developmental delay, developmental disorder, neurological disorder , Brain injury, neurometabolic disorder, stroke, attention deficit disorder, attention deficit hyperactivity disorder, aper syndrome, cleft encephalopathy, gyrus hypertrophy, congenital brain malformation such as poroencephalopathy, dystonia, familial mental retardation, infant Hemiplegia, kernicterus, learning disorder, multiple cerebral infarction dementia, microcephaly, metabolic disorder with neurological complication, postmeningoencephalitis brain injury, Rubinstein-Teibi syndrome, Rett syndrome, postoperative neuropathy, Multiple sclerosis, subacute sclerosing encephalitis, and Lee's encephalopathy, Cornelia de Lange's syndrome, Japanese encephalitis, tuberous sclerosis, cerebral white matter atrophy, chromosomal abnormalities, callosal defect, spinocerebellar syndrome, etc. Disease Group, developmental disorders, also including such neurological diseases, may be effective in some non-limiting neurologic abnormalities thereto.

  The homeopathic formulations according to the invention are stable, non-toxic and without any side effects.

  The homeopathic formulation of the present invention is easy to dispense.

  Furthermore, the present homeopathic formulation can be combined with other homeopathic formulations to obtain the desired effect.

  The homeopathic preparation of the present invention is a common preparation for several neurological diseases and does not require individualization of drugs using a single drug component per dose, as has been practiced in conventional homeopathy. is there.

  Published homeopathic formulations are cost effective and treatment costs are not as effective.

  While the importance of various features of preferred embodiments is strongly emphasized in this document, it is understood that many changes and modifications to the preferred embodiments can occur without departing from the principles of the present invention. It is highly appreciated. These and other modifications to this preferred embodiment and other embodiments of the present invention are to be clearly understood as to the interpretation that the above description is merely illustrative and not restrictive. Need to be clear to the parties to the disclosure.

Claims (19)

A formulation for treating neurological disease comprising a tincture consisting of: or a homeopathic formulation together with a physiologically acceptable carrier.

At least one selected from the first group containing onion (Allium cepa), Arnica montana (Arnica montana), daisies (Bellis perennis), calendula (Calendula officinalis), Sturgeon (Hypericum perforatum), and phosphoric acid (Phosphoricum acidum) component

Aconitum (Aconitum napellus), Alumina (Alumina), Peyote Cactus (Anahalonium lewini), Silver Nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenide trioxide (Arsenicum album), Belladonna (Belladonna), Blue Khosh (Caulophyllum thalictroides), Causticum, Causticum, Cocculus indicus, Poisonous Ginseng (Conium maculatum), Copper (Cuprum metallicum), Curare, Curuka, Dulcamara, Red Ant (Formica rufa), Carolina Jasmin (Gelsemium sempervirens), Hypericum perforatum, potassium iodide (Kalium iodatum), potassium tartaricum (Kalium tartaricum), American rhubarb (Kalmia latifolia), bushmaster (Lachesis mutus), glass bean (Lathyrus sativus) Latrodectus hasselti), manganese acetate Tate (Manganum aceticum), mercuric chloride (Mercurius corrosivus), matin (Nux vomica), oxalic acid (Oxalicum acidum), white phosphorus (Phosphorus), carabalu bean (Physostigma venenosum), picric acid (Picricum acidum), plumbiacetate At least one selected from the second group containing (Plumbum aceticum), poison (Rhus toxicodendron), ergot (Secale cornutum), strykininpurum (Strychninum purum), thallium (Thaelium metallicum), and thoroidinum (Thyroidinum) component

Silver nitrate (Argentum nitricum), atropine (Atropinum), aurum metallicum (Aurum metallicum), barium carbonate (Baryta carbonica), Belladonna (Belladonna), oyster shell nacre (Calcarea carbonica), potassium hydroxide (Causticum), Greater selandin (Chelidonium majus), rattlefish snake (Crotalus horridus), yellow jasmine (Gelsemium sempervirens), blue sweet pea (Lathyrus sativus), lycopodium clavatum, martin (Nux vomica), oxalic acid (Oxalicumum) Containing (Phosphorus), Calabar (Physostigma venenosum), Lead (Plumbum metallicum), Crystal (Slicea terra), Strychninum purum, Sulfur (Sulphur), Tarantula (Tarentula hispanica), and Thuja occidentalis At least one component selected from three groups

From the fourth group that contains barium carbonate (Baryta carbonica), oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), potassium hydroxide (Causticum), sodium chloride (Natrium muriaticum), and crystal (Silicea terra) Selected at least one ingredient

Mugwort (Absinthium), aconit (Aconitum napellus), dog parsley (Aethusa cynapium), Amaranth (Agnus castus), aluminum (Alumina), ambragricia (Ambra grisea), marking nut (Anacardium orientale), aurora cactus (Anhalonium) lewinii), silver nitrate (Argentum nitricum), arnica montana (Arnica montana), gold (Aurum metallicum), neem (Azadirachta indica), barium carbonate (Baryta carbonica), marigold (Calendula officinalis), pearl layer of oyster shell ( Calcarea carbonica, calcium phosphate (Calcarea phosphorica), camphora officinalis (Camphora officinalis), Indian cannabis (Cannabis indica), plant charcoal (Carbo vegitabilis), Tussock ginseng (Cocculus indicus), poisonous ginseng (Conium maculatum), glycerin (Glycerinum) ), Ifthyol (Ichthyolum), potassium bromide (Kalium Bromatum), potassium carbonate (Kalium carbonicum), potassium phosphate (Kalium phosphoricum), dog's milk (Lac caninu), bushmaster (Lachesis mutus), lecithin (Lecithinum), hinocangula (Lycopodium clavatum), gonorrhea Medorrhinum), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), sodium carbonate (Natrium carbonicum), sodium chloride (Natrium muriaticum), nitric acid (Nitricum acidum), nutmeg (Nux moschata), matin (Nux vomica), ole Under = 夾 桃 (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), lead (Plumicum metallicum), rhodedendron (Rhododendron chrysanthum) Poison ivy and poison oak (Rhus toxicodendron), selenium (Selenium metallicum), Europe Squid squid (Sepia officinalis), crystal (Silicea terra), sulfur (Sulphur), rigid lower exudate (Syphilinum) of patients with syphilis, tellurium (Tellurium metallicum), thyroidinum (Thyroidinum), zinc (Zincum metallicum), zincic acid (Zincum) phosphoricum, at least one component selected from the fifth group containing zinc picrate (Zincum picricum)

Ohio Horse Chestnut (Aesculus glabra), Agaricus muscarius (Agaricus muscarius), Marking Nut (Anacardium orientale), Ubatama Cactus (Anhalonium lewinii), Atropininum (Atropninum), Barium Carbonate (Baryta carbonica), Belladonna (Belladonna), Hellopus luciferus ), Bovista licoperdon (Bovista lycoperdon), European toad (Buforana), cannabis (Cannabis indica), hemp (Cannabis sativa), potassium hydroxide (Causticum), cereus serpentinus (Cereus serpentinus), doxcilli (Cicuta virosa) ), Copper (Cuprum metallicum), Yellow jasmine (Gelsemium sempervirens), Hyos (Hyoscyamus niger), Ignatius beans (Ignatia amara), Potassium bromide (Kalium bromatum), Potassium cyanide (Kalium cyanatum), Bushmaster (Lachesis mutus), Bacchi Arhus (Laurocerasus), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), South African pink toe (Mygale lasiodora), Indian cobra (Naja tripudians), sodium chloride (Natrium muriaticum), nutmeg (Nux moschata), oleander = Containing Peach bamboo peach (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), white phosphorus (Phosphorus), chrysanthemum (Stramonium), sulphonalum (Sulfonalum), black-and-white sorrel (Thuja occidentalis), and the European goldfish (Vipera berus) At least one component selected from six groups

Dog parsley (Aethusa cynapium), Sambusia nirvana (Ailanthus glandulosa), alfalfa (Alfalfa), marking nut (Anacardium orientale), Ubata cactus (Anhalonium lewinii), silver nitrate (Argentum nitricum), oat (Avena sativa), Wild indigo , Oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), coca (Coca-Erythroxylon coca), clover (Cocculus indicus), copper (Cuprum metallicum), yellow jasmine (Gelsemium sempervirens), potassium bromide (Kalium) Bromatum), potassium phosphate (Kalium phosphoricum), lecithin (Lecithinum), sodium chloride (Natrium muriaticum), matin (Nux vomica), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), (Silicea terra), strychnine neric acid (Stychninum phosphori (cum), zinc (Zincum metallicum), zinc acid (Zincum phosphoricum), zinc picrate (Zincum picricum) at least one component selected from the seventh group containing

Belladonna (Belladonna), Toad Toad (Buforana), Spanish moth (Cantharis vesicatoria), Copper (Cuprum metallicum), Hyos (Hyoscyamus niger), Tiger Lily (Lilium tigrinum), Ercorn (Secale cornutum), Chosen Asagao (Stramonium) At least one component selected from the eighth group containing Tarantula (Tarentula hispanica), Veratrum album, and

Horse mackerel (Aconitum napellus), Agaricus muscarius (Agaricus muscarius), Bee (Apis mellifica), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenic trioxide (Arsenicum album), atropine (Atropinum), veradonna (Atropinum) Belladonna), benzoicum acidum, oyster shell nacre (Calcarea carbonica), spanish salmon (Cantharis vesicatoria), potassium hydroxide (Causticum), dokuseri (Cicuta virosa), American ginger (Cimicifuga racemosa), Sina Maritina (Cina maritima), Poisonous Ginseng (Conium maculatum), Woody Nightshade (Dulcamara), Toxa (Equisetum hyemale), Eryngium aquaticum (Eryngium aquaticum), Bone Set (Eupatorium perfoliatum), Joe Pi Suites (Eupatorium purpureum) ), Iron (Ferrum metallicum), iron phosphate (Ferrum) phosphoricum, yellow jasmine (Gelsemium sempervirens), hydrangea (Hydrangea arborescens), hyos (Hyoscyamus niger), potassium bromide (Kalium bromatum), potassium nitrate (Kalium nitricum), potassium phosphate (Kalium phosphorousum), cleosome (Kreosotum) ), Liana vulgaris, lupulus humulus, lycopodium clavatum, magnesium phosphate (Magnasia phosphorica), gonorrhea (Medorrhinum), matin (Nux vomica), poppy (Opium-Papaver omnium) Petroleum (Petroleum), Phosphoric acid (Phosphoricum acidum), Calaba bean (Physostigma venenosum), Horseradish (Plantago major), Horsetail (Pulsatilla pratensis), Rhushi (Rhus aromatica), Poison Ivy and Poisoned Oak (Rhus nicotinose) Sabal serrulata), Sanuki in Ottawa Cretaceous water (Sanicula aqua), Santonin (Santoninum), Ercorn (Secale cornutum), Senega (Senega), Eurasian Squid (Sepia officinalis), Crystal (Silica terra), Ginseng (Stramonium), Sulfur (Sulphur), Tv oil (Terebinthiniae oleum), Thyroidinum, Thuja occidentalis, Triticum repens-Agropyrum repens, Tuberculinum bovinum Kent, Uranium nitrate (Uranium niutilus) And at least one component selected from the ninth group containing zinc (Zincum metallicum)   The formulations claimed in claim 1 are effective for treating human and animal neurological diseases.   The formulation claimed in claim 1 is a tincture component.   The formulation claimed in claim 1 is a solution in ethanol.   The formulation as claimed in claim 1 is an extract wherein the component is aqueous.   The formulation claimed in claim 1 is fortified.   The formulations claimed in claim 1 are fortified with their respective components.   The preparation claimed in claim 1 has all the X, C, LM potency from the tincture in the extract, preferably around 30 C to 1 M.   The formulation claimed in claim 1 is characterized in that the physiologically acceptable carrier is whey, sucrose, calcium carbonate, microcrystalline cellulose, carbon, carnauba wax, croscarmellose sodium, stearic acid, magnesium stearate, dioxide It is selected from the group consisting of silicon and ethanol.   The formulation as claimed in claim 1 has the amount of each component of the group having a width of about 1: 1 to 1:10 with respect to the amount of the other group. A formulation for treating neurological diseases, comprising the following ingredients together with a physiologically acceptable carrier:
i) Arnica montana
ii) Hypericum perforatum
iii) Causticum
iv) Hyos (Hyoscyamus niger)
v) Zinc acid (Zincum phosphoricum)
vi) Sodium chloride (Natrium muriaticum)
vii) Calcium phosphate (Calcarea phosphorica)
viii) potassium phosphate (Kalium phosphoricum) and
ix) Iron phosphate (Ferrum phosphoricum) A formulation for treating neurological diseases, comprising the following ingredients together with a physiologically acceptable carrier:
i) Daisies (Bellis perennis)
ii) Pearl layer of oyster shell (Calcarea carbonica)
iii) Alfalfa
iv) Oat (Avena sativa)
v) Zinc (Zincum metallicum)
vi) Clove Asagao (Stramonium)
vii) Causticum
viii) Sodium chloride (Natrium muriaticum) and
ix) Potassium phosphate (Kalium phosphoricum)   The formulations claimed in all the preceding claims take a form selected from the group consisting of tablets, capsules, powders, globules, lozenges, pills, pellets, solutions, syrups, elixirs, suspensions, emulsions. The pharmaceutical method of treating a neurological disease comprises the following steps.
i) Selected from the first group comprising selected onion (Allium cepa), Arnica montana (Arnica montana), daisies (Bellis perennis), calendula (Calendula officinalis), European hypericum (Hypericum perforatum), phosphoric acid (Phosphoricum acidum) At least one ingredient

Aconitum (Aconitum napellus), Alumina (Alumina), Peyote Cactus (Anahalonium lewini), Silver Nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenide trioxide (Arsenicum album), Belladonna (Belladonna), Blue Khosh (Caulophyllum thalictroides), Causticum, Causticum, Cocculus indicus, Poisonous Ginseng (Conium maculatum), Copper (Cuprum metallicum), Curare, Curuka, Dulcamara, Red Ant (Formica rufa), Carolina Jasmin (Gelsemium sempervirens), Hypericum perforatum, potassium iodide (Kalium iodatum), potassium tartaricum (Kalium tartaricum), American rhubarb (Kalmia latifolia), bushmaster (Lachesis mutus), glass bean (Lathyrus sativus) Latrodectus hasselti), manganese acetate Tate (Manganum aceticum), mercuric chloride (Mercurius corrosivus), matin (Nux vomica), oxalic acid (Oxalicum acidum), white phosphorus (Phosphorus), carabalu bean (Physostigma venenosum), picric acid (Picricum acidum), plumbiacetate At least one selected from the second group containing (Plumbum aceticum), poison (Rhus toxicodendron), ergot (Secale cornutum), strykininpurum (Strychninum purum), thallium (Thaelium metallicum), and thoroidinum (Thyroidinum) component

Silver nitrate (Argentum nitricum), atropine (Atropinum), aurum metallicum (Aurum metallicum), barium carbonate (Baryta carbonica), Belladonna (Belladonna), oyster shell nacre (Calcarea carbonica), potassium hydroxide (Causticum), Greater selandin (Chelidonium majus), rattlefish snake (Crotalus horridus), yellow jasmine (Gelsemium sempervirens), blue sweet pea (Lathyrus sativus), lycopodium clavatum, martin (Nux vomica), oxalic acid (Oxalicumum) Containing (Phosphorus), Calabar (Physostigma venenosum), Lead (Plumbum metallicum), Crystal (Slicea terra), Strychninum purum, Sulfur (Sulphur), Tarantula (Tarentula hispanica), and Thuja occidentalis At least one component selected from three groups

From the fourth group that contains barium carbonate (Baryta carbonica), oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), potassium hydroxide (Causticum), sodium chloride (Natrium muriaticum), and crystal (Silicea terra) Selected at least one ingredient

Mugwort (Absinthium), aconit (Aconitum napellus), dog parsley (Aethusa cynapium), Amaranth (Agnus castus), aluminum (Alumina), ambragricia (Ambra grisea), marking nut (Anacardium orientale), aurora cactus (Anhalonium) lewinii), silver nitrate (Argentum nitricum), arnica montana (Arnica montana), gold (Aurum metallicum), neem (Azadirachta indica), barium carbonate (Baryta carbonica), marigold (Calendula officinalis), pearl layer of oyster shell ( Calcarea carbonica, calcium phosphate (Calcarea phosphorica), camphora officinalis (Camphora officinalis), Indian cannabis (Cannabis indica), plant charcoal (Carbo vegitabilis), Tussock ginseng (Cocculus indicus), poisonous ginseng (Conium maculatum), glycerin (Glycerinum) ), Ifthyol (Ichthyolum), potassium bromide (Kalium Bromatum), potassium carbonate (Kalium carbonicum), potassium phosphate (Kalium phosphoricum), dog's milk (Lac caninu), bushmaster (Lachesis mutus), lecithin (Lecithinum), hinocangula (Lycopodium clavatum), gonorrhea Medorrhinum), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), sodium carbonate (Natrium carbonicum), sodium chloride (Natrium muriaticum), nitric acid (Nitricum acidum), nutmeg (Nux moschata), matin (Nux vomica), ole Under = 夾 桃 (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), lead (Plumicum metallicum), rhodedendron (Rhododendron chrysanthum) Poison ivy and poison oak (Rhus toxicodendron), selenium (Selenium metallicum), Europe Squid squid (Sepia officinalis), crystal (Silicea terra), sulfur (Sulphur), rigid lower exudate (Syphilinum) of patients with syphilis, tellurium (Tellurium metallicum), thyroidinum (Thyroidinum), zinc (Zincum metallicum), zincic acid (Zincum) phosphoricum, at least one component selected from the fifth group containing zinc picrate (Zincum picricum)

Ohio Horse Chestnut (Aesculus glabra), Agaricus muscarius (Agaricus muscarius), Marking Nut (Anacardium orientale), Ubatama Cactus (Anhalonium lewinii), Atropininum (Atropninum), Barium Carbonate (Baryta carbonica), Belladonna (Belladonna), Hellopus luciferus ), Bovista licoperdon (Bovista lycoperdon), European toad (Buforana), cannabis (Cannabis indica), hemp (Cannabis sativa), potassium hydroxide (Causticum), cereus serpentinus (Cereus serpentinus), doxcilli (Cicuta virosa) ), Copper (Cuprum metallicum), Yellow jasmine (Gelsemium sempervirens), Hyos (Hyoscyamus niger), Ignatius beans (Ignatia amara), Potassium bromide (Kalium bromatum), Potassium cyanide (Kalium cyanatum), Bushmaster (Lachesis mutus), Bacchi Arhus (Laurocerasus), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), South African pink toe (Mygale lasiodora), Indian cobra (Naja tripudians), sodium chloride (Natrium muriaticum), nutmeg (Nux moschata), oleander = Containing Peach bamboo peach (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), white phosphorus (Phosphorus), chrysanthemum (Stramonium), sulphonalum (Sulfonalum), black-and-white sorrel (Thuja occidentalis), and the European goldfish (Vipera berus) At least one component selected from six groups

Dog parsley (Aethusa cynapium), Sambusia nirvana (Ailanthus glandulosa), alfalfa (Alfalfa), marking nut (Anacardium orientale), Ubata cactus (Anhalonium lewinii), silver nitrate (Argentum nitricum), oat (Avena sativa), Wild indigo , Oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), coca (Coca-Erythroxylon coca), clover (Cocculus indicus), copper (Cuprum metallicum), yellow jasmine (Gelsemium sempervirens), potassium bromide (Kalium) Bromatum), potassium phosphate (Kalium phosphoricum), lecithin (Lecithinum), sodium chloride (Natrium muriaticum), matin (Nux vomica), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), (Silicea terra), strychnine neric acid (Stychninum phosphori (cum), zinc (Zincum metallicum), zinc acid (Zincum phosphoricum), zinc picrate (Zincum picricum) at least one component selected from the seventh group containing

Belladonna (Belladonna), Toad Toad (Buforana), Spanish moth (Cantharis vesicatoria), Copper (Cuprum metallicum), Hyos (Hyoscyamus niger), Tiger Lily (Lilium tigrinum), Ercorn (Secale cornutum), Chosen Asagao (Stramonium) At least one component selected from the eighth group containing Tarantula (Tarentula hispanica), Veratrum album, and

Horse mackerel (Aconitum napellus), Agaricus muscarius (Agaricus muscarius), Bee (Apis mellifica), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenic trioxide (Arsenicum album), atropine (Atropinum), veradonna (Atropinum) Belladonna), benzoicum acidum, oyster shell nacre (Calcarea carbonica), spanish salmon (Cantharis vesicatoria), potassium hydroxide (Causticum), dokuseri (Cicuta virosa), American ginger (Cimicifuga racemosa), Sina Maritina (Cina maritima), Poisonous Ginseng (Conium maculatum), Woody Nightshade (Dulcamara), Toxa (Equisetum hyemale), Eryngium aquaticum (Eryngium aquaticum), Bone Set (Eupatorium perfoliatum), Joe Pi Suites (Eupatorium purpureum) ), Iron (Ferrum metallicum), iron phosphate (Ferrum) phosphoricum, yellow jasmine (Gelsemium sempervirens), hydrangea (Hydrangea arborescens), hyos (Hyoscyamus niger), potassium bromide (Kalium bromatum), potassium nitrate (Kalium nitricum), potassium phosphate (Kalium phosphorousum), cleosome (Kreosotum) ), Liana vulgaris, lupulus humulus, lycopodium clavatum, magnesium phosphate (Magnasia phosphorica), gonorrhea (Medorrhinum), matin (Nux vomica), poppy (Opium-Papaver omnium) Petroleum (Petroleum), Phosphoric acid (Phosphoricum acidum), Calaba bean (Physostigma venenosum), Horseradish (Plantago major), Horsetail (Pulsatilla pratensis), Rhushi (Rhus aromatica), Poison Ivy and Poisoned Oak (Rhus nicotinose) Sabal serrulata), Sanuki in Ottawa Cretaceous water (Sanicula aqua), Santonin (Santoninum), Ercorn (Secale cornutum), Senega (Senega), Eurasian Squid (Sepia officinalis), Crystal (Silica terra), Ginseng (Stramonium), Sulfur (Sulphur), Tv oil (Terebinthiniae oleum), Thyroidinum, Thuja occidentalis, Triticum repens-Agropyrum repens, Tuberculinum bovinum Kent, Uranium nitrate (Uranium niutilus) And at least one component selected from the ninth group containing zinc (Zincum metallicum)

ii) making a mixture containing the selected components in a ratio of about 1: 1 to 1:10 with respect to the other group

iii) Dilute the mixture with a liquid carrier selected from water or ethanol to obtain a potent mixture between tincture and all the potency of X, C, LM, as far as possible in the range of 30 C to 1 M ,further

iv) Immerse the carrier globule in the dilution mixture to obtain the formulation
  The method of formulation claimed in claim 14 strengthens the respective selected components in a ratio of about 1: 1 to 1:10 relative to the other group to a homeopathic flow initially with a liquid carrier selected from water or ethanol, The potency between the tincture and all the potency of X, C, LM, preferably from 30 C to 1 M, is mixed and soaked in carrier globule.   Formulation claimed in claim 14, wherein the carrier globule is sucrose globule or lactose globule. A method of treating a neurological disorder in a subject, said method comprising administering a dose with enhanced efficacy of a formulation comprising an extract from: ing.

At least one selected from the first group containing onion (Allium cepa), Arnica montana (Arnica montana), daisies (Bellis perennis), calendula (Calendula officinalis), Sturgeon (Hypericum perforatum), and phosphoric acid (Phosphoricum acidum) component

Aconitum (Aconitum napellus), Alumina (Alumina), Peyote Cactus (Anahalonium lewini), Silver Nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenide trioxide (Arsenicum album), Belladonna (Belladonna), Blue Khosh (Caulophyllum thalictroides), Causticum, Causticum, Cocculus indicus, Poisonous Ginseng (Conium maculatum), Copper (Cuprum metallicum), Curare, Curuka, Dulcamara, Red Ant (Formica rufa), Carolina Jasmin (Gelsemium sempervirens), Hypericum perforatum, potassium iodide (Kalium iodatum), potassium tartaricum (Kalium tartaricum), American rhubarb (Kalmia latifolia), bushmaster (Lachesis mutus), glass bean (Lathyrus sativus) Latrodectus hasselti), manganese acetate Tate (Manganum aceticum), mercuric chloride (Mercurius corrosivus), matin (Nux vomica), oxalic acid (Oxalicum acidum), white phosphorus (Phosphorus), carabalu bean (Physostigma venenosum), picric acid (Picricum acidum), plumbiacetate At least one selected from the second group containing (Plumbum aceticum), poison (Rhus toxicodendron), ergot (Secale cornutum), strykininpurum (Strychninum purum), thallium (Thaelium metallicum), and thoroidinum (Thyroidinum) component

Silver nitrate (Argentum nitricum), atropine (Atropinum), aurum metallicum (Aurum metallicum), barium carbonate (Baryta carbonica), Belladonna (Belladonna), oyster shell nacre (Calcarea carbonica), potassium hydroxide (Causticum), Greater selandin (Chelidonium majus), rattlefish snake (Crotalus horridus), yellow jasmine (Gelsemium sempervirens), blue sweet pea (Lathyrus sativus), lycopodium clavatum, martin (Nux vomica), oxalic acid (Oxalicumum) Containing (Phosphorus), Calabar (Physostigma venenosum), Lead (Plumbum metallicum), Crystal (Slicea terra), Strychninum purum, Sulfur (Sulphur), Tarantula (Tarentula hispanica), and Thuja occidentalis At least one component selected from three groups

From the fourth group that contains barium carbonate (Baryta carbonica), oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), potassium hydroxide (Causticum), sodium chloride (Natrium muriaticum), and crystal (Silicea terra) Selected at least one ingredient

Mugwort (Absinthium), aconit (Aconitum napellus), dog parsley (Aethusa cynapium), Amaranth (Agnus castus), aluminum (Alumina), ambragricia (Ambra grisea), marking nut (Anacardium orientale), aurora cactus (Anhalonium) lewinii), silver nitrate (Argentum nitricum), arnica montana (Arnica montana), gold (Aurum metallicum), neem (Azadirachta indica), barium carbonate (Baryta carbonica), marigold (Calendula officinalis), pearl layer of oyster shell ( Calcarea carbonica, calcium phosphate (Calcarea phosphorica), camphora officinalis (Camphora officinalis), Indian cannabis (Cannabis indica), plant charcoal (Carbo vegitabilis), Tussock ginseng (Cocculus indicus), poisonous ginseng (Conium maculatum), glycerin (Glycerinum) ), Ifthyol (Ichthyolum), potassium bromide (Kalium Bromatum), potassium carbonate (Kalium carbonicum), potassium phosphate (Kalium phosphoricum), dog's milk (Lac caninu), bushmaster (Lachesis mutus), lecithin (Lecithinum), hinocangula (Lycopodium clavatum), gonorrhea Medorrhinum), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), sodium carbonate (Natrium carbonicum), sodium chloride (Natrium muriaticum), nitric acid (Nitricum acidum), nutmeg (Nux moschata), matin (Nux vomica), ole Under = 夾 桃 (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), lead (Plumicum metallicum), rhodedendron (Rhododendron chrysanthum) Poison ivy and poison oak (Rhus toxicodendron), selenium (Selenium metallicum), Europe Squid squid (Sepia officinalis), crystal (Silicea terra), sulfur (Sulphur), rigid lower exudate (Syphilinum) of patients with syphilis, tellurium (Tellurium metallicum), thyroidinum (Thyroidinum), zinc (Zincum metallicum), zincic acid (Zincum) phosphoricum, at least one component selected from the fifth group containing zinc picrate (Zincum picricum)

Ohio Horse Chestnut (Aesculus glabra), Agaricus muscarius (Agaricus muscarius), Marking Nut (Anacardium orientale), Ubatama Cactus (Anhalonium lewinii), Atropininum, Barium Carbonate (Baryta carbonica), Belladonna (Belladonna), Bacillus Chirocerus ), Bovista licoperdon (Bovista lycoperdon), European toad (Buforana), cannabis (Cannabis indica), hemp (Cannabis sativa), potassium hydroxide (Causticum), cereus serpentinus (Cereus serpentinus), doxcilli (Cicuta virosa) ), Copper (Cuprum metallicum), Yellow jasmine (Gelsemium sempervirens), Hyos (Hyoscyamus niger), Ignatius beans (Ignatia amara), Potassium bromide (Kalium bromatum), Potassium cyanide (Kalium cyanatum), Bushmaster (Lachesis mutus), Bacchi Ki (Laurocerasus), Mercurius sorbilis = Mercury (Mercurius solubilis-Hydargyrum), South African pink toe (Mygale lasiodora), Indian cobra (Naja tripudians), sodium chloride (Natrium muriaticum), nutmeg (Nux moschata), oleander = Containing No. bamboo peach (Oleander-Nerium odorum), poppy (Opium-Papaver somniferum), white phosphorus (Phosphorus), chrysanthemum (Stramonium), Sulfonalum (Sulfonalum), European sturgeon (Thuja occidentalis), and the European snapper (Vipera berus) At least one component selected from six groups

Dog parsley (Aethusa cynapium), Sambusia nirvana (Ailanthus glandulosa), alfalfa (Alfalfa), marking nut (Anacardium orientale), Ubata cactus (Anhalonium lewinii), silver nitrate (Argentum nitricum), oat (Avena sativa), Wild indigo , Oyster shell nacre (Calcarea carbonica), calcium phosphate (Calcarea phosphorica), coca (Coca-Erythroxylon coca), clover (Cocculus indicus), copper (Cuprum metallicum), yellow jasmine (Gelsemium sempervirens), potassium bromide (Kalium) Bromatum), potassium phosphate (Kalium phosphoricum), lecithin (Lecithinum), sodium chloride (Natrium muriaticum), matin (Nux vomica), phosphoric acid (Phosphoricum acidum), white phosphorus (Phosphorus), picric acid (Picricum acidum), (Silicea terra), strychnine neric acid (Stychninum phosphori (cum), zinc (Zincum metallicum), zinc acid (Zincum phosphoricum), zinc picrate (Zincum picricum) at least one component selected from the seventh group containing

Belladonna (Belladonna), Toad Toad (Buforana), Spanish moth (Cantharis vesicatoria), Copper (Cuprum metallicum), Hyos (Hyoscyamus niger), Tiger Lily (Lilium tigrinum), Ercorn (Secale cornutum), Chosen Asagao (Stramonium) At least one component selected from the eighth group containing Tarantula (Tarentula hispanica), Veratrum album, and

Horse mackerel (Aconitum napellus), Agaricus muscarius (Agaricus muscarius), Bee (Apis mellifica), silver nitrate (Argentum nitricum), Arnica montana (Arnica montana), Arsenic trioxide (Arsenicum album), atropine (Atropinum), veradonna (Atropinum) Belladonna), benzoicum acidum, oyster shell nacre (Calcarea carbonica), spanish salmon (Cantharis vesicatoria), potassium hydroxide (Causticum), dokuseri (Cicuta virosa), American ginger (Cimicifuga racemosa), Sina Maritina (Cina maritima), Poisonous Ginseng (Conium maculatum), Woody Nightshade (Dulcamara), Toxa (Equisetum hyemale), Eryngium aquaticum (Eryngium aquaticum), Bone Set (Eupatorium perfoliatum), Joe Pi Suites (Eupatorium purpureum) ), Iron (Ferrum metallicum), iron phosphate (Ferrum) phosphoricum, yellow jasmine (Gelsemium sempervirens), hydrangea (Hydrangea arborescens), hyos (Hyoscyamus niger), potassium bromide (Kalium bromatum), potassium nitrate (Kalium nitricum), potassium phosphate (Kalium phosphorousum), cleosome (Kreosotum) ), Liana vulgaris, lupulus humulus, lycopodium clavatum, magnesium phosphate (Magnasia phosphorica), gonorrhea (Medorrhinum), matin (Nux vomica), poppy (Opium-Papaver omnium) Petroleum (Petroleum), Phosphoric acid (Phosphoricum acidum), Calaba bean (Physostigma venenosum), Horseradish (Plantago major), Horsetail (Pulsatilla pratensis), Rhushi (Rhus aromatica), Poison Ivy and Poisoned Oak (Rhus nicotinose) Sabal serrulata), Sanuki in Ottawa Cretaceous water (Sanicula aqua), Santonin (Santoninum), Ercorn (Secale cornutum), Senega (Senega), Eurasian Squid (Sepia officinalis), Crystal (Silica terra), Ginseng (Stramonium), Sulfur (Sulphur), Tv oil (Terebinthiniae oleum), Thyroidinum, Thuja occidentalis, Scutellariae Triticum repens-Agropyrum repens, Tuberculinum bovinum Kent, Uranium nitrate And at least one component selected from the ninth group containing zinc (Zincum metallicum)   The formulations claimed in all of the preceding claims are selected from the group consisting of the neurological diseases of interest: Spastic cerebral palsy (spastic, hyptonic, athetoid), ataxia cerebral palsy, intellectual disability, depression due to neurological disease, autism, down syndrome, overall developmental delay, developmental disorder, neuropathy, brain damage, neurometabolic Disorders, stroke, attention deficit disorder, attention deficit hyperactivity disorder, apela syndrome, cleft encephalopathy, congenital brain malformation such as gyrus hypertrophy, porencephalythmia, dystonia, familial mental retardation, infantile hemiplegia, nuclear jaundice, learning Disorder, multiple cerebral infarction dementia, microcephaly, metabolic disorder with neurological complications, postmeningoencephalitis brain injury, Rubinstein-Teibi syndrome, Rett syndrome, postoperative neuropathy, multiple sclerosis, subacute Various syndromes such as sclerosing whole encephalitis and Lee encephalopathy, Cornelia de Lange's syndrome, Japanese encephalitis, tuberous sclerosis, cerebral white matter atrophy, chromosomal abnormalities, corpus callosum defect, spinocerebellar syndrome, developmental disorders, Neurological Such as patients.   Formulations and methods substantially as described with reference to the accompanying examples.